Project
avrg: GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for MECP2
Z-value: 6.87
Motif logo
Transcription factors associated with MECP2
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
MECP2
|
ENSG00000169057.24 | MECP2 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| MECP2 | hg38_v1_chrX_-_154097668_154097728 | -0.14 | 3.8e-02 | Click! |
Activity profile of MECP2 motif
Sorted Z-values of MECP2 motif
Network of associatons between targets according to the STRING database.
First level regulatory network of MECP2
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 15.7 | 47.1 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
| 12.7 | 50.7 | GO:0042247 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 11.8 | 58.9 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
| 11.6 | 46.5 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 11.1 | 44.3 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 11.0 | 33.0 | GO:1902905 | positive regulation of fibril organization(GO:1902905) |
| 10.8 | 43.3 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
| 10.7 | 42.7 | GO:0036496 | regulation of translational initiation by eIF2 alpha dephosphorylation(GO:0036496) |
| 10.3 | 41.4 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 10.0 | 30.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 9.7 | 9.7 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
| 9.7 | 38.7 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 9.4 | 37.5 | GO:1903976 | negative regulation of glial cell migration(GO:1903976) |
| 8.9 | 26.6 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
| 8.8 | 35.1 | GO:0046778 | modification by virus of host mRNA processing(GO:0046778) |
| 8.8 | 35.1 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 8.7 | 26.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 8.5 | 34.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 8.3 | 58.2 | GO:0032218 | riboflavin transport(GO:0032218) |
| 8.3 | 24.8 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
| 8.2 | 41.0 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
| 8.1 | 48.6 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
| 8.0 | 24.1 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 7.9 | 23.7 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 7.8 | 31.1 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
| 7.7 | 38.4 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 7.6 | 38.1 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 7.2 | 21.7 | GO:0035732 | nitric oxide storage(GO:0035732) |
| 7.2 | 21.6 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
| 7.2 | 28.7 | GO:0048627 | myoblast development(GO:0048627) |
| 7.1 | 50.0 | GO:0030421 | defecation(GO:0030421) |
| 7.0 | 21.1 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 7.0 | 28.0 | GO:0032599 | B cell receptor transport within lipid bilayer(GO:0032595) B cell receptor transport into membrane raft(GO:0032597) protein transport out of membrane raft(GO:0032599) chemokine receptor transport out of membrane raft(GO:0032600) negative regulation of transforming growth factor beta3 production(GO:0032913) chemokine receptor transport within lipid bilayer(GO:0033606) |
| 7.0 | 62.8 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
| 6.9 | 20.7 | GO:1902524 | positive regulation of protein K48-linked ubiquitination(GO:1902524) |
| 6.7 | 33.6 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
| 6.7 | 13.4 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
| 6.7 | 20.1 | GO:0070476 | RNA (guanine-N7)-methylation(GO:0036265) rRNA (guanine-N7)-methylation(GO:0070476) |
| 6.7 | 40.1 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 6.7 | 20.0 | GO:0019322 | xylulose biosynthetic process(GO:0005999) pentose biosynthetic process(GO:0019322) |
| 6.6 | 33.2 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 6.5 | 6.5 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 6.5 | 38.7 | GO:0006235 | dTTP biosynthetic process(GO:0006235) deoxyribonucleoside triphosphate biosynthetic process(GO:0009202) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
| 6.4 | 6.4 | GO:1903921 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
| 6.3 | 57.0 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
| 6.3 | 25.1 | GO:0009439 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 6.0 | 114.6 | GO:1904874 | positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
| 6.0 | 48.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 6.0 | 23.8 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 5.9 | 29.7 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
| 5.9 | 11.8 | GO:0009133 | ADP biosynthetic process(GO:0006172) nucleoside diphosphate biosynthetic process(GO:0009133) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
| 5.9 | 17.7 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 5.9 | 17.6 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
| 5.8 | 17.5 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
| 5.8 | 34.8 | GO:0006050 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 5.8 | 17.3 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
| 5.7 | 17.2 | GO:1904845 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
| 5.7 | 57.1 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 5.7 | 17.0 | GO:0075732 | viral penetration into host nucleus(GO:0075732) multi-organism nuclear import(GO:1902594) |
| 5.6 | 5.6 | GO:0060623 | regulation of chromosome condensation(GO:0060623) |
| 5.5 | 16.6 | GO:0071816 | tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 5.5 | 27.3 | GO:0071033 | nuclear retention of pre-mRNA at the site of transcription(GO:0071033) |
| 5.4 | 59.8 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
| 5.4 | 5.4 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
| 5.4 | 27.1 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
| 5.3 | 31.8 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
| 5.3 | 15.9 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
| 5.3 | 42.0 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
| 5.2 | 15.6 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
| 5.2 | 5.2 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
| 5.0 | 35.3 | GO:0015866 | ADP transport(GO:0015866) |
| 5.0 | 15.1 | GO:0014810 | positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014810) |
| 4.9 | 29.7 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
| 4.9 | 24.6 | GO:1902896 | terminal web assembly(GO:1902896) |
| 4.8 | 19.4 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
| 4.8 | 14.5 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 4.8 | 4.8 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 4.8 | 9.6 | GO:0042255 | ribosome assembly(GO:0042255) |
| 4.8 | 19.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
| 4.8 | 14.3 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 4.7 | 37.8 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
| 4.7 | 41.9 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
| 4.6 | 23.1 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
| 4.6 | 4.6 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
| 4.5 | 26.9 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
| 4.4 | 8.9 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 4.4 | 26.5 | GO:0097052 | L-kynurenine metabolic process(GO:0097052) |
| 4.4 | 13.2 | GO:1902568 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
| 4.4 | 21.9 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 4.4 | 8.7 | GO:1904872 | regulation of telomerase RNA localization to Cajal body(GO:1904872) |
| 4.3 | 17.3 | GO:0042450 | arginine biosynthetic process via ornithine(GO:0042450) |
| 4.3 | 38.9 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 4.3 | 38.7 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 4.3 | 4.3 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
| 4.3 | 4.3 | GO:0006591 | ornithine metabolic process(GO:0006591) |
| 4.3 | 34.2 | GO:0032077 | positive regulation of deoxyribonuclease activity(GO:0032077) |
| 4.3 | 8.5 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 4.3 | 29.8 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
| 4.2 | 16.6 | GO:0070425 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
| 4.1 | 12.2 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
| 4.1 | 8.1 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 4.1 | 4.1 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
| 4.1 | 12.2 | GO:0070902 | mitochondrial tRNA pseudouridine synthesis(GO:0070902) |
| 4.0 | 28.3 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 4.0 | 16.1 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 4.0 | 4.0 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
| 4.0 | 52.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
| 3.9 | 11.8 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 3.9 | 62.8 | GO:0043248 | proteasome assembly(GO:0043248) |
| 3.9 | 7.8 | GO:0000967 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 3.9 | 15.6 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
| 3.9 | 3.9 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 3.8 | 15.3 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 3.8 | 19.0 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) |
| 3.8 | 30.4 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
| 3.8 | 15.1 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
| 3.8 | 33.9 | GO:0006265 | DNA topological change(GO:0006265) |
| 3.7 | 15.0 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 3.7 | 7.5 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 3.7 | 11.2 | GO:0043328 | protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 3.7 | 18.7 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
| 3.7 | 18.6 | GO:1900368 | regulation of RNA interference(GO:1900368) negative regulation of RNA interference(GO:1900369) |
| 3.7 | 11.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 3.7 | 7.3 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
| 3.6 | 14.3 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
| 3.6 | 17.9 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 3.6 | 17.8 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 3.5 | 21.2 | GO:0007296 | vitellogenesis(GO:0007296) |
| 3.5 | 7.0 | GO:0002424 | T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) |
| 3.5 | 10.5 | GO:0002184 | cytoplasmic translational termination(GO:0002184) |
| 3.5 | 24.5 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 3.5 | 10.5 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
| 3.5 | 3.5 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
| 3.4 | 6.9 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 3.4 | 10.3 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
| 3.4 | 3.4 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 3.4 | 48.0 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 3.4 | 30.6 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 3.4 | 10.1 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 3.3 | 46.8 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 3.3 | 3.3 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
| 3.3 | 3.3 | GO:0097069 | response to human chorionic gonadotropin(GO:0044752) cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
| 3.3 | 13.3 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
| 3.3 | 13.3 | GO:1903758 | regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
| 3.3 | 16.5 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 3.3 | 23.1 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
| 3.3 | 3.3 | GO:0051095 | regulation of helicase activity(GO:0051095) |
| 3.3 | 226.7 | GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
| 3.3 | 19.6 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
| 3.3 | 29.4 | GO:0007619 | courtship behavior(GO:0007619) |
| 3.3 | 13.1 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
| 3.2 | 16.2 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
| 3.2 | 3.2 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 3.2 | 9.7 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
| 3.2 | 16.0 | GO:1903333 | negative regulation of protein folding(GO:1903333) |
| 3.2 | 12.8 | GO:1904569 | regulation of selenocysteine incorporation(GO:1904569) |
| 3.2 | 12.8 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 3.2 | 22.1 | GO:1904896 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 3.1 | 12.6 | GO:0099640 | axo-dendritic protein transport(GO:0099640) |
| 3.1 | 6.3 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
| 3.1 | 3.1 | GO:0005985 | sucrose metabolic process(GO:0005985) |
| 3.1 | 40.5 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 3.1 | 18.7 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 3.1 | 31.0 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
| 3.1 | 9.3 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
| 3.1 | 9.2 | GO:0042946 | glucoside transport(GO:0042946) |
| 3.1 | 12.2 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
| 3.1 | 36.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 3.0 | 9.1 | GO:0000393 | spliceosomal conformational changes to generate catalytic conformation(GO:0000393) |
| 3.0 | 60.0 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 3.0 | 101.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
| 3.0 | 11.9 | GO:0009956 | radial pattern formation(GO:0009956) |
| 3.0 | 11.9 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
| 3.0 | 47.5 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
| 3.0 | 11.9 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
| 3.0 | 23.7 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 2.9 | 223.0 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
| 2.9 | 17.6 | GO:1904431 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) positive regulation of t-circle formation(GO:1904431) |
| 2.9 | 11.7 | GO:0032262 | pyrimidine ribonucleotide salvage(GO:0010138) pyrimidine nucleotide salvage(GO:0032262) UMP salvage(GO:0044206) |
| 2.9 | 17.5 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 2.9 | 14.5 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
| 2.9 | 2.9 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
| 2.9 | 8.7 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
| 2.9 | 11.6 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
| 2.9 | 20.2 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
| 2.9 | 40.3 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 2.9 | 2.9 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
| 2.9 | 14.3 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
| 2.9 | 11.4 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
| 2.8 | 11.4 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
| 2.8 | 19.9 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 2.8 | 2.8 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 2.8 | 19.8 | GO:1902915 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 2.8 | 19.7 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
| 2.8 | 11.2 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 2.8 | 13.9 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 2.8 | 30.5 | GO:0007144 | female meiosis I(GO:0007144) |
| 2.8 | 8.3 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 2.8 | 11.0 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) negative regulation of male germ cell proliferation(GO:2000255) |
| 2.7 | 27.4 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
| 2.7 | 123.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 2.7 | 21.9 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 2.7 | 54.6 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 2.7 | 2.7 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
| 2.7 | 8.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 2.7 | 5.4 | GO:1903378 | positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 2.7 | 24.2 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 2.7 | 10.7 | GO:0031125 | rRNA 3'-end processing(GO:0031125) |
| 2.7 | 26.6 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
| 2.7 | 8.0 | GO:0060957 | endocardial cell fate commitment(GO:0060957) endocardial cushion cell fate commitment(GO:0061445) |
| 2.6 | 13.2 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
| 2.6 | 15.9 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 2.6 | 13.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
| 2.6 | 7.8 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
| 2.6 | 7.8 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 2.6 | 2.6 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
| 2.6 | 5.1 | GO:2000234 | regulation of ribosome biogenesis(GO:0090069) positive regulation of ribosome biogenesis(GO:0090070) regulation of rRNA processing(GO:2000232) positive regulation of rRNA processing(GO:2000234) |
| 2.6 | 23.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 2.6 | 7.7 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 2.5 | 10.1 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
| 2.5 | 15.2 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 2.5 | 22.5 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 2.5 | 2.5 | GO:0061218 | negative regulation of mesonephros development(GO:0061218) |
| 2.5 | 12.4 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 2.5 | 34.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 2.4 | 9.8 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
| 2.4 | 19.5 | GO:0044351 | macropinocytosis(GO:0044351) |
| 2.4 | 7.3 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 2.4 | 14.6 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
| 2.4 | 7.3 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 2.4 | 7.3 | GO:2000174 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
| 2.4 | 2.4 | GO:0060596 | mammary placode formation(GO:0060596) |
| 2.4 | 7.2 | GO:0042823 | pyridoxal phosphate metabolic process(GO:0042822) pyridoxal phosphate biosynthetic process(GO:0042823) |
| 2.4 | 7.2 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 2.4 | 9.6 | GO:0072683 | T cell extravasation(GO:0072683) |
| 2.4 | 4.8 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
| 2.4 | 14.3 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
| 2.4 | 2.4 | GO:1905214 | regulation of RNA binding(GO:1905214) |
| 2.4 | 4.7 | GO:2000374 | regulation of oxygen metabolic process(GO:2000374) |
| 2.4 | 4.7 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 2.4 | 14.1 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
| 2.4 | 51.8 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 2.4 | 16.5 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
| 2.4 | 4.7 | GO:0003162 | atrioventricular node development(GO:0003162) |
| 2.4 | 18.8 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 2.3 | 11.7 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 2.3 | 2.3 | GO:0051884 | regulation of anagen(GO:0051884) |
| 2.3 | 9.2 | GO:0061188 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 2.3 | 13.7 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
| 2.3 | 11.4 | GO:0043418 | homocysteine catabolic process(GO:0043418) |
| 2.3 | 6.8 | GO:1903382 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 2.3 | 27.3 | GO:0046689 | response to mercury ion(GO:0046689) |
| 2.3 | 9.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
| 2.3 | 4.5 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
| 2.3 | 2.3 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 2.3 | 6.8 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 2.2 | 13.5 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
| 2.2 | 20.2 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 2.2 | 6.7 | GO:0003420 | regulation of growth plate cartilage chondrocyte proliferation(GO:0003420) |
| 2.2 | 17.8 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 2.2 | 20.0 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 2.2 | 6.7 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
| 2.2 | 15.5 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 2.2 | 13.3 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 2.2 | 8.8 | GO:0030047 | actin modification(GO:0030047) |
| 2.2 | 17.6 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 2.2 | 17.6 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 2.2 | 8.8 | GO:0001765 | membrane raft assembly(GO:0001765) |
| 2.2 | 11.0 | GO:0070269 | pyroptosis(GO:0070269) |
| 2.2 | 4.4 | GO:0070309 | lens fiber cell morphogenesis(GO:0070309) |
| 2.2 | 13.1 | GO:0070836 | caveola assembly(GO:0070836) |
| 2.2 | 6.5 | GO:0034239 | macrophage fusion(GO:0034238) regulation of macrophage fusion(GO:0034239) positive regulation of macrophage fusion(GO:0034241) |
| 2.2 | 13.0 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 2.2 | 17.3 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 2.1 | 10.7 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
| 2.1 | 145.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 2.1 | 17.1 | GO:0051014 | actin filament severing(GO:0051014) |
| 2.1 | 6.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 2.1 | 6.4 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
| 2.1 | 10.6 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 2.1 | 4.2 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 2.1 | 6.3 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 2.1 | 6.3 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
| 2.1 | 6.3 | GO:1904897 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
| 2.1 | 29.4 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
| 2.1 | 10.5 | GO:2000035 | regulation of stem cell division(GO:2000035) |
| 2.1 | 12.6 | GO:1900223 | positive regulation of beta-amyloid clearance(GO:1900223) |
| 2.1 | 18.8 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
| 2.1 | 16.7 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
| 2.1 | 35.6 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
| 2.1 | 294.7 | GO:0045047 | protein targeting to ER(GO:0045047) |
| 2.1 | 6.3 | GO:0070625 | zymogen granule exocytosis(GO:0070625) |
| 2.1 | 31.3 | GO:0000338 | protein deneddylation(GO:0000338) |
| 2.1 | 4.1 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 2.1 | 22.8 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 2.1 | 14.5 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 2.1 | 29.0 | GO:0033750 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 2.1 | 8.2 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
| 2.1 | 10.3 | GO:0015862 | uridine transport(GO:0015862) |
| 2.1 | 22.7 | GO:1903944 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
| 2.1 | 67.8 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 2.0 | 12.2 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
| 2.0 | 14.1 | GO:0072733 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 2.0 | 10.1 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 2.0 | 10.1 | GO:0003164 | His-Purkinje system development(GO:0003164) |
| 2.0 | 2.0 | GO:0060066 | oviduct development(GO:0060066) |
| 2.0 | 2.0 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
| 2.0 | 12.0 | GO:0061198 | fungiform papilla development(GO:0061196) fungiform papilla morphogenesis(GO:0061197) fungiform papilla formation(GO:0061198) |
| 2.0 | 14.0 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
| 2.0 | 8.0 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
| 2.0 | 2.0 | GO:0048254 | snoRNA localization(GO:0048254) |
| 2.0 | 10.0 | GO:0060613 | fat pad development(GO:0060613) |
| 2.0 | 6.0 | GO:0002678 | positive regulation of chronic inflammatory response(GO:0002678) |
| 2.0 | 11.9 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 2.0 | 11.8 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 2.0 | 5.9 | GO:0010225 | response to UV-C(GO:0010225) |
| 2.0 | 5.9 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 2.0 | 5.9 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 2.0 | 2.0 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
| 2.0 | 3.9 | GO:0090151 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) establishment of protein localization to mitochondrial membrane(GO:0090151) |
| 1.9 | 21.4 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 1.9 | 75.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 1.9 | 1.9 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
| 1.9 | 3.8 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 1.9 | 30.6 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 1.9 | 19.0 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 1.9 | 5.7 | GO:0038091 | coronary vein morphogenesis(GO:0003169) VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 1.9 | 13.1 | GO:0009249 | protein lipoylation(GO:0009249) |
| 1.9 | 20.5 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 1.9 | 42.8 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
| 1.9 | 9.3 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
| 1.9 | 5.6 | GO:1901355 | response to rapamycin(GO:1901355) |
| 1.9 | 5.6 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 1.8 | 46.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 1.8 | 20.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 1.8 | 9.2 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 1.8 | 7.3 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
| 1.8 | 42.1 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
| 1.8 | 16.5 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 1.8 | 11.0 | GO:2000825 | positive regulation of androgen receptor activity(GO:2000825) |
| 1.8 | 62.1 | GO:0090383 | phagosome acidification(GO:0090383) |
| 1.8 | 7.3 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 1.8 | 3.6 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
| 1.8 | 1.8 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 1.8 | 21.7 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 1.8 | 7.2 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 1.8 | 28.8 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 1.8 | 77.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 1.8 | 7.2 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
| 1.8 | 3.6 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 1.8 | 7.1 | GO:0002084 | protein depalmitoylation(GO:0002084) |
| 1.8 | 1.8 | GO:0061443 | endocardial cushion cell differentiation(GO:0061443) |
| 1.8 | 3.5 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 1.8 | 5.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 1.8 | 8.8 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
| 1.7 | 5.2 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 1.7 | 3.5 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) positive regulation of thyroid hormone generation(GO:2000611) |
| 1.7 | 5.2 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
| 1.7 | 5.2 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 1.7 | 12.1 | GO:0072718 | response to cisplatin(GO:0072718) |
| 1.7 | 1.7 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
| 1.7 | 5.2 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
| 1.7 | 3.4 | GO:0051177 | meiotic sister chromatid cohesion(GO:0051177) |
| 1.7 | 11.9 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 1.7 | 8.5 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
| 1.7 | 30.7 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 1.7 | 20.4 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 1.7 | 8.5 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 1.7 | 3.4 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
| 1.7 | 5.0 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 1.7 | 3.4 | GO:2000491 | hepatic stellate cell activation(GO:0035733) regulation of hepatic stellate cell activation(GO:2000489) positive regulation of hepatic stellate cell activation(GO:2000491) |
| 1.7 | 1.7 | GO:2000561 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
| 1.7 | 36.6 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
| 1.7 | 26.5 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
| 1.7 | 6.6 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
| 1.7 | 5.0 | GO:1904528 | positive regulation of microtubule binding(GO:1904528) |
| 1.6 | 24.7 | GO:0060056 | mammary gland involution(GO:0060056) |
| 1.6 | 4.9 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 1.6 | 4.9 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 1.6 | 35.7 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
| 1.6 | 13.0 | GO:1903593 | regulation of histamine secretion by mast cell(GO:1903593) |
| 1.6 | 24.2 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
| 1.6 | 22.6 | GO:0030497 | fatty acid elongation(GO:0030497) very long-chain fatty acid biosynthetic process(GO:0042761) |
| 1.6 | 4.8 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 1.6 | 56.2 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
| 1.6 | 6.4 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
| 1.6 | 1.6 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) positive regulation of toll-like receptor 3 signaling pathway(GO:0034141) |
| 1.6 | 6.4 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 1.6 | 12.8 | GO:0030091 | protein repair(GO:0030091) |
| 1.6 | 36.6 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 1.6 | 6.4 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 1.6 | 14.3 | GO:0001866 | NK T cell proliferation(GO:0001866) |
| 1.6 | 7.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 1.6 | 6.3 | GO:0042262 | DNA protection(GO:0042262) |
| 1.6 | 25.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
| 1.6 | 9.4 | GO:0042407 | cristae formation(GO:0042407) |
| 1.5 | 9.3 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
| 1.5 | 24.6 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 1.5 | 3.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
| 1.5 | 3.1 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
| 1.5 | 16.8 | GO:0038203 | TORC2 signaling(GO:0038203) |
| 1.5 | 15.2 | GO:0033227 | dsRNA transport(GO:0033227) |
| 1.5 | 19.7 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 1.5 | 3.0 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
| 1.5 | 29.9 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
| 1.5 | 34.3 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
| 1.5 | 13.3 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
| 1.5 | 7.4 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
| 1.5 | 2.9 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
| 1.5 | 5.8 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
| 1.5 | 67.2 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 1.5 | 16.0 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
| 1.5 | 40.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 1.5 | 4.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
| 1.5 | 14.5 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 1.5 | 10.2 | GO:0015846 | polyamine transport(GO:0015846) |
| 1.4 | 14.4 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 1.4 | 8.6 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 1.4 | 10.1 | GO:1902659 | regulation of glucose mediated signaling pathway(GO:1902659) |
| 1.4 | 12.9 | GO:0033631 | cell-cell adhesion mediated by integrin(GO:0033631) |
| 1.4 | 7.2 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) negative regulation of establishment of T cell polarity(GO:1903904) negative regulation of T cell migration(GO:2000405) negative regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001107) |
| 1.4 | 21.4 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 1.4 | 4.3 | GO:1903487 | cellular triglyceride homeostasis(GO:0035356) regulation of lactation(GO:1903487) |
| 1.4 | 24.1 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
| 1.4 | 2.8 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 1.4 | 1.4 | GO:0072204 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
| 1.4 | 9.8 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 1.4 | 9.8 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
| 1.4 | 4.2 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 1.4 | 2.8 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
| 1.4 | 4.2 | GO:0030961 | peptidyl-arginine hydroxylation(GO:0030961) |
| 1.4 | 5.5 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
| 1.4 | 20.7 | GO:0006241 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
| 1.4 | 4.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 1.4 | 1.4 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 1.4 | 1.4 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
| 1.4 | 4.1 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 1.4 | 2.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 1.4 | 10.8 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
| 1.3 | 6.7 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 1.3 | 45.8 | GO:0031648 | protein destabilization(GO:0031648) |
| 1.3 | 16.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 1.3 | 8.0 | GO:0072553 | terminal button organization(GO:0072553) |
| 1.3 | 2.7 | GO:0043382 | regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) |
| 1.3 | 6.7 | GO:1903896 | positive regulation of IRE1-mediated unfolded protein response(GO:1903896) |
| 1.3 | 1.3 | GO:0033206 | meiotic cytokinesis(GO:0033206) |
| 1.3 | 5.3 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 1.3 | 4.0 | GO:0021814 | cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration(GO:0021815) |
| 1.3 | 4.0 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 1.3 | 7.9 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 1.3 | 23.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 1.3 | 5.2 | GO:0043335 | protein unfolding(GO:0043335) |
| 1.3 | 21.0 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
| 1.3 | 9.2 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 1.3 | 10.5 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 1.3 | 85.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 1.3 | 3.9 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 1.3 | 1.3 | GO:0043366 | beta selection(GO:0043366) |
| 1.3 | 37.4 | GO:0006337 | nucleosome disassembly(GO:0006337) |
| 1.3 | 7.7 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 1.3 | 5.1 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 1.3 | 9.0 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
| 1.3 | 5.1 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
| 1.3 | 5.1 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
| 1.3 | 3.8 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 1.3 | 6.4 | GO:1902262 | apoptotic process involved in patterning of blood vessels(GO:1902262) |
| 1.3 | 2.5 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 1.3 | 18.8 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 1.3 | 25.0 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 1.3 | 5.0 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 1.2 | 3.7 | GO:0051182 | coenzyme transport(GO:0051182) |
| 1.2 | 17.4 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 1.2 | 75.7 | GO:0035722 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
| 1.2 | 7.4 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 1.2 | 14.9 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 1.2 | 13.6 | GO:0006596 | polyamine biosynthetic process(GO:0006596) |
| 1.2 | 7.4 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
| 1.2 | 12.3 | GO:0032905 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
| 1.2 | 20.9 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 1.2 | 6.1 | GO:0006574 | valine catabolic process(GO:0006574) |
| 1.2 | 1.2 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
| 1.2 | 9.8 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
| 1.2 | 8.5 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
| 1.2 | 25.5 | GO:0006465 | signal peptide processing(GO:0006465) |
| 1.2 | 1.2 | GO:1902576 | negative regulation of nuclear cell cycle DNA replication(GO:1902576) |
| 1.2 | 3.6 | GO:0043144 | snoRNA processing(GO:0043144) |
| 1.2 | 8.4 | GO:0072642 | interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 1.2 | 10.8 | GO:0051451 | myoblast migration(GO:0051451) |
| 1.2 | 51.4 | GO:0071470 | cellular response to osmotic stress(GO:0071470) |
| 1.2 | 26.2 | GO:0048255 | RNA stabilization(GO:0043489) mRNA stabilization(GO:0048255) |
| 1.2 | 16.6 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 1.2 | 3.5 | GO:0036233 | glycine import(GO:0036233) |
| 1.2 | 11.8 | GO:0045116 | protein neddylation(GO:0045116) |
| 1.2 | 7.0 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
| 1.2 | 1.2 | GO:0060268 | negative regulation of respiratory burst(GO:0060268) |
| 1.2 | 3.5 | GO:0051793 | medium-chain fatty acid catabolic process(GO:0051793) |
| 1.2 | 7.0 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
| 1.2 | 9.3 | GO:0070200 | establishment of protein localization to telomere(GO:0070200) |
| 1.2 | 11.7 | GO:0014870 | response to muscle inactivity(GO:0014870) |
| 1.2 | 26.8 | GO:1900120 | regulation of receptor binding(GO:1900120) |
| 1.2 | 19.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
| 1.2 | 3.5 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 1.2 | 1.2 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
| 1.2 | 3.5 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
| 1.2 | 21.9 | GO:0006119 | oxidative phosphorylation(GO:0006119) |
| 1.1 | 3.4 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 1.1 | 5.7 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
| 1.1 | 9.0 | GO:0006907 | pinocytosis(GO:0006907) |
| 1.1 | 13.4 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 1.1 | 12.3 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 1.1 | 5.6 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
| 1.1 | 5.6 | GO:0052572 | response to immune response of other organism involved in symbiotic interaction(GO:0052564) response to host immune response(GO:0052572) |
| 1.1 | 4.4 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
| 1.1 | 1.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
| 1.1 | 32.9 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 1.1 | 6.6 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
| 1.1 | 6.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 1.1 | 13.1 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
| 1.1 | 13.0 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
| 1.1 | 49.6 | GO:0043486 | histone exchange(GO:0043486) |
| 1.1 | 11.8 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 1.1 | 9.7 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 1.1 | 6.4 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 1.1 | 6.4 | GO:0045963 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) positive regulation of homocysteine metabolic process(GO:0050668) |
| 1.1 | 7.4 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 1.1 | 20.0 | GO:0031440 | regulation of mRNA 3'-end processing(GO:0031440) |
| 1.1 | 5.3 | GO:0043126 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 1.0 | 2.1 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
| 1.0 | 15.6 | GO:0060334 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 1.0 | 2.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
| 1.0 | 1.0 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 1.0 | 4.1 | GO:0071763 | nuclear membrane organization(GO:0071763) |
| 1.0 | 5.1 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
| 1.0 | 2.0 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 1.0 | 3.0 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 1.0 | 11.1 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
| 1.0 | 32.1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 1.0 | 15.0 | GO:0061157 | mRNA destabilization(GO:0061157) |
| 1.0 | 1.0 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 1.0 | 27.0 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
| 1.0 | 4.0 | GO:0031179 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
| 1.0 | 14.9 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 1.0 | 12.8 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
| 1.0 | 10.8 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
| 1.0 | 4.9 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
| 1.0 | 6.9 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
| 1.0 | 9.8 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
| 1.0 | 3.9 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 1.0 | 3.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 1.0 | 2.9 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
| 1.0 | 4.8 | GO:0007379 | segment specification(GO:0007379) |
| 1.0 | 3.8 | GO:1903173 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
| 1.0 | 1.9 | GO:1901970 | positive regulation of mitotic metaphase/anaphase transition(GO:0045842) positive regulation of mitotic sister chromatid separation(GO:1901970) positive regulation of metaphase/anaphase transition of cell cycle(GO:1902101) |
| 1.0 | 13.3 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.9 | 1.9 | GO:0046203 | spermidine catabolic process(GO:0046203) |
| 0.9 | 11.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.9 | 0.9 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
| 0.9 | 11.3 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.9 | 3.7 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.9 | 15.9 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
| 0.9 | 14.9 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.9 | 3.7 | GO:0061312 | BMP signaling pathway involved in heart development(GO:0061312) |
| 0.9 | 0.9 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
| 0.9 | 4.6 | GO:0042726 | riboflavin metabolic process(GO:0006771) flavin-containing compound metabolic process(GO:0042726) |
| 0.9 | 9.3 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
| 0.9 | 3.7 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) negative regulation of Schwann cell proliferation(GO:0010626) |
| 0.9 | 12.9 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
| 0.9 | 2.8 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
| 0.9 | 8.3 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.9 | 3.6 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
| 0.9 | 0.9 | GO:0072434 | signal transduction involved in G2 DNA damage checkpoint(GO:0072425) signal transduction involved in mitotic G2 DNA damage checkpoint(GO:0072434) |
| 0.9 | 3.6 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
| 0.9 | 2.7 | GO:0070512 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
| 0.9 | 5.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.9 | 2.6 | GO:0046898 | response to cycloheximide(GO:0046898) |
| 0.9 | 1.8 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
| 0.9 | 16.7 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.9 | 13.1 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.9 | 3.5 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
| 0.9 | 1.7 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
| 0.9 | 15.7 | GO:0050872 | white fat cell differentiation(GO:0050872) |
| 0.9 | 0.9 | GO:2001025 | positive regulation of response to drug(GO:2001025) |
| 0.9 | 3.4 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
| 0.9 | 2.6 | GO:1900194 | negative regulation of oocyte maturation(GO:1900194) |
| 0.9 | 6.0 | GO:0001712 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.9 | 6.0 | GO:0042791 | 5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.9 | 1.7 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
| 0.8 | 3.4 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
| 0.8 | 1.7 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
| 0.8 | 5.0 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.8 | 6.7 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.8 | 0.8 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
| 0.8 | 69.8 | GO:0090114 | COPII-coated vesicle budding(GO:0090114) |
| 0.8 | 24.1 | GO:0008210 | estrogen metabolic process(GO:0008210) |
| 0.8 | 0.8 | GO:0033182 | regulation of histone ubiquitination(GO:0033182) |
| 0.8 | 4.1 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.8 | 2.5 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
| 0.8 | 4.1 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
| 0.8 | 3.3 | GO:1904782 | negative regulation of glutamate receptor signaling pathway(GO:1900450) negative regulation of NMDA glutamate receptor activity(GO:1904782) |
| 0.8 | 3.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
| 0.8 | 11.4 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
| 0.8 | 4.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.8 | 3.2 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) |
| 0.8 | 7.3 | GO:1990000 | amyloid fibril formation(GO:1990000) |
| 0.8 | 7.2 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.8 | 3.2 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
| 0.8 | 7.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
| 0.8 | 0.8 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) negative regulation of mRNA catabolic process(GO:1902373) |
| 0.8 | 0.8 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.8 | 3.9 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
| 0.8 | 7.0 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.8 | 2.3 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
| 0.8 | 20.3 | GO:0045911 | positive regulation of DNA recombination(GO:0045911) |
| 0.8 | 13.2 | GO:0006903 | vesicle targeting(GO:0006903) |
| 0.8 | 8.5 | GO:0006527 | arginine catabolic process(GO:0006527) |
| 0.8 | 10.0 | GO:0019054 | modulation by virus of host process(GO:0019054) |
| 0.8 | 0.8 | GO:0006267 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
| 0.8 | 1.5 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
| 0.8 | 6.1 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
| 0.8 | 3.8 | GO:0009648 | photoperiodism(GO:0009648) |
| 0.8 | 8.3 | GO:0017121 | phospholipid scrambling(GO:0017121) |
| 0.8 | 2.3 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.8 | 1.5 | GO:2000317 | negative regulation of T-helper 17 type immune response(GO:2000317) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 0.8 | 0.8 | GO:0098917 | retrograde trans-synaptic signaling(GO:0098917) |
| 0.7 | 12.7 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.7 | 4.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
| 0.7 | 2.9 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.7 | 1.5 | GO:0061739 | protein lipidation involved in autophagosome assembly(GO:0061739) |
| 0.7 | 4.3 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
| 0.7 | 0.7 | GO:0032816 | positive regulation of natural killer cell activation(GO:0032816) |
| 0.7 | 1.4 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
| 0.7 | 0.7 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.7 | 7.2 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.7 | 2.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
| 0.7 | 10.7 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.7 | 19.7 | GO:0006625 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.7 | 6.3 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.7 | 2.8 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.7 | 17.8 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.7 | 0.7 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
| 0.7 | 2.0 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
| 0.7 | 6.8 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.7 | 13.6 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.7 | 3.4 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.7 | 6.0 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
| 0.7 | 8.7 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.7 | 4.0 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.7 | 6.6 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.7 | 21.9 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
| 0.7 | 0.7 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 0.7 | 1.3 | GO:0040031 | snRNA modification(GO:0040031) |
| 0.6 | 7.8 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.6 | 1.9 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
| 0.6 | 3.2 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
| 0.6 | 1.3 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
| 0.6 | 1.9 | GO:0002305 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
| 0.6 | 5.2 | GO:0016139 | glycoside catabolic process(GO:0016139) |
| 0.6 | 27.0 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
| 0.6 | 1.9 | GO:0051795 | positive regulation of hair follicle maturation(GO:0048818) positive regulation of catagen(GO:0051795) |
| 0.6 | 10.2 | GO:0035456 | response to interferon-beta(GO:0035456) |
| 0.6 | 1.9 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.6 | 6.3 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
| 0.6 | 5.1 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
| 0.6 | 0.6 | GO:0010273 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) stress response to copper ion(GO:1990169) |
| 0.6 | 5.7 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
| 0.6 | 3.8 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
| 0.6 | 1.9 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
| 0.6 | 1.9 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
| 0.6 | 2.5 | GO:0018201 | N-terminal protein myristoylation(GO:0006499) N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
| 0.6 | 1.9 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.6 | 8.5 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
| 0.6 | 4.8 | GO:0046040 | IMP metabolic process(GO:0046040) |
| 0.6 | 0.6 | GO:2001023 | regulation of response to drug(GO:2001023) |
| 0.6 | 278.3 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
| 0.6 | 3.0 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
| 0.6 | 1.2 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
| 0.6 | 0.6 | GO:0071306 | cellular response to vitamin E(GO:0071306) |
| 0.6 | 24.1 | GO:0006414 | translational elongation(GO:0006414) |
| 0.6 | 4.6 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
| 0.6 | 2.3 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.6 | 4.6 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
| 0.6 | 1.7 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 0.6 | 5.1 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
| 0.6 | 8.0 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
| 0.6 | 4.5 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.6 | 3.9 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.6 | 1.7 | GO:0090188 | signal transduction by trans-phosphorylation(GO:0023016) negative regulation of pancreatic juice secretion(GO:0090188) |
| 0.6 | 9.5 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.6 | 1.1 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.6 | 1.1 | GO:0031393 | negative regulation of prostaglandin biosynthetic process(GO:0031393) |
| 0.6 | 2.2 | GO:0032462 | regulation of protein homooligomerization(GO:0032462) |
| 0.6 | 9.4 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.6 | 2.2 | GO:0015677 | copper ion import(GO:0015677) |
| 0.5 | 1.6 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.5 | 11.5 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.5 | 1.1 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.5 | 1.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
| 0.5 | 17.3 | GO:0051642 | centrosome localization(GO:0051642) |
| 0.5 | 5.9 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
| 0.5 | 0.5 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.5 | 2.7 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
| 0.5 | 0.5 | GO:0002905 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.5 | 6.9 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.5 | 2.1 | GO:0051382 | kinetochore assembly(GO:0051382) |
| 0.5 | 1.6 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
| 0.5 | 3.7 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
| 0.5 | 2.6 | GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition(GO:0051437) |
| 0.5 | 0.5 | GO:0090186 | regulation of pancreatic juice secretion(GO:0090186) |
| 0.5 | 8.8 | GO:0006101 | citrate metabolic process(GO:0006101) |
| 0.5 | 1.6 | GO:0060166 | olfactory pit development(GO:0060166) |
| 0.5 | 7.8 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
| 0.5 | 29.8 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
| 0.5 | 2.1 | GO:0003409 | optic vesicle morphogenesis(GO:0003404) optic cup structural organization(GO:0003409) |
| 0.5 | 10.2 | GO:0006739 | NADP metabolic process(GO:0006739) |
| 0.5 | 24.0 | GO:0051289 | protein homotetramerization(GO:0051289) |
| 0.5 | 3.6 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
| 0.5 | 7.1 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
| 0.5 | 1.5 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
| 0.5 | 4.1 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
| 0.5 | 6.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.5 | 2.5 | GO:0051639 | actin filament network formation(GO:0051639) |
| 0.5 | 4.0 | GO:0006517 | protein deglycosylation(GO:0006517) |
| 0.5 | 5.5 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
| 0.5 | 2.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.5 | 2.0 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.5 | 2.4 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
| 0.5 | 1.0 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.5 | 1.0 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 0.5 | 4.3 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
| 0.5 | 11.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.5 | 1.9 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.5 | 1.0 | GO:0002326 | B cell lineage commitment(GO:0002326) |
| 0.5 | 1.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.5 | 2.8 | GO:0032757 | positive regulation of interleukin-8 production(GO:0032757) |
| 0.5 | 1.9 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.5 | 4.7 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.5 | 9.3 | GO:0006491 | N-glycan processing(GO:0006491) |
| 0.5 | 1.4 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.5 | 0.9 | GO:0015853 | adenine transport(GO:0015853) |
| 0.5 | 5.0 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
| 0.5 | 1.4 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
| 0.4 | 2.2 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.4 | 2.2 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
| 0.4 | 4.9 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.4 | 3.1 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.4 | 8.7 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
| 0.4 | 0.4 | GO:0072599 | establishment of protein localization to endoplasmic reticulum(GO:0072599) |
| 0.4 | 1.3 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
| 0.4 | 2.6 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.4 | 2.1 | GO:0033080 | immature T cell proliferation in thymus(GO:0033080) |
| 0.4 | 2.5 | GO:0060356 | leucine import(GO:0060356) |
| 0.4 | 3.0 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.4 | 0.8 | GO:0019048 | modulation by virus of host morphology or physiology(GO:0019048) |
| 0.4 | 3.8 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.4 | 2.5 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
| 0.4 | 3.3 | GO:0031034 | myosin filament assembly(GO:0031034) |
| 0.4 | 1.2 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
| 0.4 | 16.1 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
| 0.4 | 26.8 | GO:0030049 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.4 | 2.5 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.4 | 0.4 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.4 | 2.0 | GO:0044387 | negative regulation of protein kinase activity by regulation of protein phosphorylation(GO:0044387) |
| 0.4 | 0.8 | GO:0003245 | growth involved in heart morphogenesis(GO:0003241) cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.4 | 4.0 | GO:1901072 | glucosamine-containing compound catabolic process(GO:1901072) |
| 0.4 | 0.8 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) chemorepulsion of axon(GO:0061643) |
| 0.4 | 0.8 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
| 0.4 | 9.5 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.4 | 3.9 | GO:0001778 | plasma membrane repair(GO:0001778) |
| 0.4 | 0.8 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.4 | 1.2 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
| 0.4 | 1.2 | GO:0043584 | nose development(GO:0043584) |
| 0.4 | 1.5 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.4 | 4.2 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.4 | 4.2 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.4 | 1.5 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
| 0.4 | 4.1 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.4 | 11.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.4 | 4.9 | GO:0006379 | mRNA cleavage(GO:0006379) |
| 0.4 | 8.2 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.4 | 3.0 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
| 0.4 | 1.1 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.4 | 12.1 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.4 | 4.3 | GO:0097205 | renal filtration(GO:0097205) |
| 0.4 | 2.2 | GO:0006554 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
| 0.4 | 5.0 | GO:0051923 | sulfation(GO:0051923) |
| 0.3 | 2.1 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.3 | 3.8 | GO:0003184 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
| 0.3 | 5.4 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
| 0.3 | 1.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
| 0.3 | 2.0 | GO:0036257 | multivesicular body organization(GO:0036257) |
| 0.3 | 4.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
| 0.3 | 1.7 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
| 0.3 | 11.6 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.3 | 1.7 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
| 0.3 | 7.3 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.3 | 2.6 | GO:0050702 | interleukin-1 beta secretion(GO:0050702) |
| 0.3 | 6.6 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
| 0.3 | 1.0 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
| 0.3 | 2.3 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.3 | 5.1 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.3 | 1.0 | GO:0071462 | cellular response to water deprivation(GO:0042631) cellular response to water stimulus(GO:0071462) |
| 0.3 | 2.5 | GO:0071421 | manganese ion transmembrane transport(GO:0071421) |
| 0.3 | 1.6 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
| 0.3 | 2.5 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
| 0.3 | 1.3 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.3 | 1.9 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
| 0.3 | 3.4 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.3 | 1.9 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.3 | 0.9 | GO:0061009 | common bile duct development(GO:0061009) |
| 0.3 | 0.9 | GO:0097264 | self proteolysis(GO:0097264) |
| 0.3 | 0.9 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
| 0.3 | 0.6 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
| 0.3 | 23.7 | GO:0006364 | rRNA processing(GO:0006364) |
| 0.3 | 2.7 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.3 | 0.6 | GO:0051657 | maintenance of organelle location(GO:0051657) |
| 0.3 | 16.0 | GO:0006413 | translational initiation(GO:0006413) |
| 0.3 | 3.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.3 | 0.9 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
| 0.3 | 0.3 | GO:0060426 | lung vasculature development(GO:0060426) |
| 0.3 | 1.7 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
| 0.3 | 0.9 | GO:0033385 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
| 0.3 | 3.5 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
| 0.3 | 0.3 | GO:0090169 | regulation of spindle assembly(GO:0090169) |
| 0.3 | 2.2 | GO:0060033 | anatomical structure regression(GO:0060033) |
| 0.3 | 0.8 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
| 0.3 | 1.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.3 | 16.8 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
| 0.3 | 1.1 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.3 | 11.7 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
| 0.3 | 1.5 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.3 | 5.8 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.3 | 9.6 | GO:0006334 | nucleosome assembly(GO:0006334) |
| 0.3 | 1.3 | GO:0046618 | drug export(GO:0046618) |
| 0.2 | 7.0 | GO:0061462 | protein localization to lysosome(GO:0061462) |
| 0.2 | 12.9 | GO:0045669 | positive regulation of osteoblast differentiation(GO:0045669) |
| 0.2 | 1.0 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.2 | 0.2 | GO:0001916 | positive regulation of T cell mediated cytotoxicity(GO:0001916) |
| 0.2 | 1.4 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
| 0.2 | 5.0 | GO:0006743 | ubiquinone metabolic process(GO:0006743) |
| 0.2 | 1.2 | GO:1901662 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
| 0.2 | 0.2 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
| 0.2 | 0.9 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.2 | 14.5 | GO:0019079 | viral genome replication(GO:0019079) |
| 0.2 | 0.9 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
| 0.2 | 4.1 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.2 | 3.0 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.2 | 0.9 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.2 | 6.6 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
| 0.2 | 0.7 | GO:0098543 | detection of bacterium(GO:0016045) detection of other organism(GO:0098543) |
| 0.2 | 1.1 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.2 | 0.7 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
| 0.2 | 2.0 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
| 0.2 | 0.9 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
| 0.2 | 1.7 | GO:0035994 | response to muscle stretch(GO:0035994) |
| 0.2 | 3.6 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.2 | 1.7 | GO:0042401 | amine biosynthetic process(GO:0009309) cellular biogenic amine biosynthetic process(GO:0042401) |
| 0.2 | 1.7 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.2 | 0.4 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
| 0.2 | 2.9 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
| 0.2 | 0.8 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.2 | 0.4 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
| 0.2 | 1.0 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
| 0.2 | 1.0 | GO:0071459 | protein localization to chromosome, centromeric region(GO:0071459) |
| 0.2 | 0.6 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
| 0.2 | 1.2 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
| 0.2 | 3.5 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.2 | 1.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.2 | 1.0 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
| 0.2 | 5.4 | GO:0060416 | response to growth hormone(GO:0060416) |
| 0.2 | 0.4 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
| 0.2 | 2.7 | GO:0060487 | lung epithelial cell differentiation(GO:0060487) |
| 0.2 | 1.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.2 | 0.7 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
| 0.2 | 0.3 | GO:0006983 | ER overload response(GO:0006983) |
| 0.2 | 2.5 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
| 0.2 | 1.9 | GO:0070293 | renal absorption(GO:0070293) |
| 0.2 | 0.3 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
| 0.2 | 0.5 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
| 0.2 | 0.5 | GO:0044532 | modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) modulation by symbiont of host programmed cell death(GO:0052040) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) |
| 0.2 | 2.7 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
| 0.2 | 0.5 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.2 | 1.0 | GO:0032026 | response to magnesium ion(GO:0032026) |
| 0.2 | 0.6 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 0.2 | 1.5 | GO:0032506 | cytokinetic process(GO:0032506) |
| 0.2 | 0.9 | GO:0098838 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
| 0.2 | 1.1 | GO:0009404 | toxin metabolic process(GO:0009404) |
| 0.1 | 5.3 | GO:0008033 | tRNA processing(GO:0008033) |
| 0.1 | 2.4 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.1 | 0.1 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
| 0.1 | 1.3 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.1 | 0.1 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
| 0.1 | 1.4 | GO:0048569 | post-embryonic organ development(GO:0048569) |
| 0.1 | 1.0 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.1 | 1.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.1 | 1.1 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.1 | 3.0 | GO:0061640 | cytoskeleton-dependent cytokinesis(GO:0061640) |
| 0.1 | 0.3 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 | 0.9 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.1 | 0.4 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.1 | 0.6 | GO:0098967 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
| 0.1 | 1.3 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.1 | 6.9 | GO:0031295 | T cell costimulation(GO:0031295) |
| 0.1 | 0.2 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
| 0.1 | 0.1 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.1 | 0.3 | GO:0015888 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
| 0.1 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
| 0.1 | 22.4 | GO:0008380 | RNA splicing(GO:0008380) |
| 0.1 | 1.3 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.1 | 0.4 | GO:0030578 | PML body organization(GO:0030578) |
| 0.1 | 0.3 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
| 0.1 | 1.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.1 | 0.1 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
| 0.1 | 0.1 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
| 0.1 | 0.4 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.1 | 0.8 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
| 0.1 | 1.2 | GO:0009206 | purine nucleoside triphosphate biosynthetic process(GO:0009145) purine ribonucleoside triphosphate biosynthetic process(GO:0009206) |
| 0.1 | 0.4 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
| 0.1 | 0.7 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
| 0.1 | 0.5 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.1 | 1.2 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
| 0.1 | 0.5 | GO:0070170 | regulation of tooth mineralization(GO:0070170) |
| 0.1 | 0.2 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
| 0.1 | 0.2 | GO:0048880 | sensory system development(GO:0048880) |
| 0.1 | 0.7 | GO:0043029 | T cell homeostasis(GO:0043029) |
| 0.1 | 0.2 | GO:1903826 | arginine transmembrane transport(GO:1903826) |
| 0.1 | 1.0 | GO:0033561 | regulation of water loss via skin(GO:0033561) |
| 0.1 | 1.2 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
| 0.1 | 2.0 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
| 0.1 | 0.2 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.1 | 0.1 | GO:0071888 | macrophage apoptotic process(GO:0071888) |
| 0.1 | 0.7 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.1 | 0.3 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.1 | 0.5 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.1 | 0.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.1 | 0.7 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
| 0.1 | 1.3 | GO:0043525 | positive regulation of neuron apoptotic process(GO:0043525) |
| 0.1 | 4.8 | GO:0002576 | platelet degranulation(GO:0002576) |
| 0.1 | 0.1 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
| 0.1 | 0.8 | GO:0045214 | sarcomere organization(GO:0045214) |
| 0.1 | 0.5 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
| 0.1 | 0.2 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
| 0.1 | 0.6 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.0 | 0.6 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.0 | 0.3 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
| 0.0 | 0.1 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
| 0.0 | 0.5 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.0 | 0.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.0 | 0.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.0 | 2.0 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
| 0.0 | 2.7 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
| 0.0 | 1.6 | GO:0002220 | innate immune response activating cell surface receptor signaling pathway(GO:0002220) stimulatory C-type lectin receptor signaling pathway(GO:0002223) |
| 0.0 | 0.1 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.0 | 0.0 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
| 0.0 | 0.1 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 0.0 | 0.0 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
| 0.0 | 0.1 | GO:0002070 | epithelial cell maturation(GO:0002070) |
| 0.0 | 0.3 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 | 0.0 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) double-strand break repair involved in meiotic recombination(GO:1990918) |
| 0.0 | 0.3 | GO:0016266 | O-glycan processing(GO:0016266) |
| 0.0 | 0.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 12.7 | 50.8 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 11.6 | 46.5 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 10.9 | 32.7 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 10.1 | 50.7 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
| 8.9 | 26.6 | GO:0044393 | microspike(GO:0044393) |
| 8.3 | 57.8 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
| 7.6 | 37.9 | GO:0031523 | Myb complex(GO:0031523) |
| 7.5 | 22.6 | GO:1990298 | mitotic checkpoint complex(GO:0033597) bub1-bub3 complex(GO:1990298) |
| 7.5 | 29.8 | GO:0071817 | MMXD complex(GO:0071817) |
| 7.3 | 44.0 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 7.0 | 7.0 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 6.9 | 62.5 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 6.6 | 33.2 | GO:0033503 | HULC complex(GO:0033503) |
| 6.5 | 71.5 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 6.3 | 63.4 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 6.3 | 37.6 | GO:0071797 | LUBAC complex(GO:0071797) |
| 6.1 | 36.7 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
| 5.9 | 70.6 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 5.9 | 11.7 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 5.7 | 39.8 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
| 5.5 | 16.6 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 5.5 | 44.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 5.5 | 38.4 | GO:0072588 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
| 5.5 | 32.7 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 5.4 | 16.3 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
| 5.4 | 21.6 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 5.3 | 58.7 | GO:0042612 | MHC class I protein complex(GO:0042612) |
| 5.3 | 47.7 | GO:0034709 | methylosome(GO:0034709) |
| 4.9 | 49.0 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 4.9 | 19.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 4.8 | 14.5 | GO:0030312 | external encapsulating structure(GO:0030312) |
| 4.8 | 57.8 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 4.8 | 28.7 | GO:0070470 | plasma membrane respiratory chain(GO:0070470) |
| 4.6 | 64.4 | GO:0070938 | contractile ring(GO:0070938) |
| 4.6 | 22.8 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 4.6 | 31.9 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 4.5 | 59.0 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
| 4.5 | 44.9 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 4.4 | 17.7 | GO:0071159 | NF-kappaB complex(GO:0071159) |
| 4.4 | 61.6 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 4.3 | 30.4 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
| 4.3 | 47.1 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 4.3 | 17.1 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 4.3 | 59.5 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 4.2 | 12.6 | GO:0043259 | laminin-10 complex(GO:0043259) |
| 4.2 | 29.3 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
| 4.2 | 12.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 4.2 | 12.5 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 4.1 | 16.6 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 3.9 | 38.8 | GO:0097255 | R2TP complex(GO:0097255) |
| 3.8 | 79.5 | GO:0022624 | proteasome accessory complex(GO:0022624) |
| 3.8 | 11.3 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
| 3.7 | 3.7 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 3.6 | 18.2 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 3.6 | 58.2 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 3.5 | 10.5 | GO:0018444 | translation release factor complex(GO:0018444) |
| 3.4 | 24.1 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 3.4 | 44.8 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 3.4 | 24.1 | GO:0016589 | NURF complex(GO:0016589) |
| 3.4 | 37.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 3.4 | 16.9 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 3.4 | 3.4 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
| 3.3 | 30.1 | GO:0042382 | paraspeckles(GO:0042382) |
| 3.3 | 16.7 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
| 3.3 | 46.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 3.3 | 39.5 | GO:0097413 | Lewy body(GO:0097413) |
| 3.3 | 52.5 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 3.3 | 26.0 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
| 3.2 | 16.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 3.2 | 90.8 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 3.2 | 9.6 | GO:0030689 | Noc complex(GO:0030689) |
| 3.2 | 63.5 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 3.1 | 15.6 | GO:0089701 | U2AF(GO:0089701) |
| 3.1 | 12.5 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 3.1 | 24.9 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 3.1 | 18.6 | GO:0097422 | tubular endosome(GO:0097422) |
| 3.1 | 6.2 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
| 3.1 | 6.1 | GO:0043203 | axon hillock(GO:0043203) |
| 3.0 | 24.3 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 3.0 | 24.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 3.0 | 39.3 | GO:0005688 | U6 snRNP(GO:0005688) |
| 3.0 | 36.0 | GO:0042555 | MCM complex(GO:0042555) |
| 3.0 | 41.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 3.0 | 29.5 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 2.9 | 8.8 | GO:0036284 | tubulobulbar complex(GO:0036284) |
| 2.9 | 11.7 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 2.9 | 113.6 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 2.9 | 11.6 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
| 2.9 | 5.8 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 2.9 | 8.6 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
| 2.8 | 11.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
| 2.8 | 19.6 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 2.7 | 27.3 | GO:0032059 | bleb(GO:0032059) |
| 2.7 | 10.9 | GO:0071942 | XPC complex(GO:0071942) |
| 2.7 | 10.9 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 2.7 | 35.0 | GO:0090543 | Flemming body(GO:0090543) |
| 2.7 | 5.4 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 2.7 | 48.0 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 2.7 | 24.0 | GO:0000125 | PCAF complex(GO:0000125) |
| 2.6 | 10.4 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
| 2.6 | 18.1 | GO:0016272 | prefoldin complex(GO:0016272) |
| 2.6 | 10.3 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
| 2.6 | 5.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 2.6 | 12.8 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 2.6 | 5.1 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 2.6 | 23.0 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
| 2.6 | 10.2 | GO:0071986 | Ragulator complex(GO:0071986) |
| 2.5 | 10.1 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 2.5 | 12.6 | GO:0034688 | integrin alphaM-beta2 complex(GO:0034688) |
| 2.5 | 22.4 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 2.5 | 32.2 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 2.5 | 12.4 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 2.4 | 4.9 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 2.4 | 7.3 | GO:0048269 | methionine adenosyltransferase complex(GO:0048269) |
| 2.4 | 7.3 | GO:0097441 | basilar dendrite(GO:0097441) |
| 2.4 | 11.9 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 2.4 | 11.8 | GO:0042825 | TAP complex(GO:0042825) |
| 2.3 | 18.7 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 2.3 | 4.6 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
| 2.3 | 16.0 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 2.3 | 2.3 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
| 2.3 | 72.7 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 2.2 | 270.1 | GO:0035578 | azurophil granule lumen(GO:0035578) |
| 2.2 | 254.6 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 2.2 | 15.3 | GO:0032021 | NELF complex(GO:0032021) |
| 2.2 | 6.5 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
| 2.2 | 36.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 2.2 | 6.5 | GO:0070288 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
| 2.1 | 2.1 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
| 2.1 | 8.5 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 2.1 | 52.0 | GO:0000502 | proteasome complex(GO:0000502) |
| 2.1 | 16.6 | GO:0000796 | condensin complex(GO:0000796) |
| 2.0 | 40.8 | GO:0032433 | filopodium tip(GO:0032433) |
| 2.0 | 6.1 | GO:1903349 | omegasome membrane(GO:1903349) |
| 2.0 | 8.1 | GO:1990246 | uniplex complex(GO:1990246) |
| 2.0 | 24.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 2.0 | 44.0 | GO:0036020 | endolysosome membrane(GO:0036020) |
| 2.0 | 8.0 | GO:0048179 | activin receptor complex(GO:0048179) |
| 2.0 | 13.9 | GO:0031415 | NatA complex(GO:0031415) |
| 2.0 | 15.8 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 2.0 | 66.4 | GO:0071564 | npBAF complex(GO:0071564) |
| 1.9 | 96.1 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 1.9 | 21.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 1.9 | 34.3 | GO:0016469 | proton-transporting two-sector ATPase complex(GO:0016469) |
| 1.9 | 9.5 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 1.9 | 9.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 1.9 | 198.3 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 1.9 | 17.0 | GO:0070652 | HAUS complex(GO:0070652) |
| 1.9 | 48.6 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
| 1.9 | 20.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 1.8 | 3.7 | GO:0030677 | ribonuclease P complex(GO:0030677) |
| 1.8 | 23.9 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 1.8 | 19.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 1.8 | 25.2 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 1.8 | 19.8 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 1.8 | 19.4 | GO:0000124 | SAGA complex(GO:0000124) |
| 1.8 | 8.8 | GO:0005682 | U5 snRNP(GO:0005682) |
| 1.7 | 5.2 | GO:0044754 | autolysosome(GO:0044754) |
| 1.7 | 7.0 | GO:1990423 | RZZ complex(GO:1990423) |
| 1.7 | 12.0 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 1.7 | 1.7 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
| 1.7 | 3.4 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
| 1.7 | 5.1 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 1.7 | 10.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 1.7 | 11.9 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 1.7 | 10.1 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 1.7 | 13.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 1.6 | 8.2 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 1.6 | 9.8 | GO:0031209 | SCAR complex(GO:0031209) |
| 1.6 | 6.5 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 1.6 | 149.0 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 1.6 | 12.9 | GO:0035976 | AP1 complex(GO:0035976) |
| 1.6 | 127.5 | GO:0070469 | respiratory chain(GO:0070469) |
| 1.6 | 4.8 | GO:0020018 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
| 1.6 | 14.3 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 1.6 | 9.4 | GO:0061617 | MICOS complex(GO:0061617) |
| 1.5 | 32.0 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 1.5 | 238.9 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
| 1.5 | 30.1 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
| 1.5 | 3.0 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
| 1.5 | 19.4 | GO:0005642 | annulate lamellae(GO:0005642) |
| 1.5 | 8.9 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 1.5 | 11.8 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 1.4 | 10.1 | GO:0030891 | VCB complex(GO:0030891) |
| 1.4 | 10.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 1.4 | 1.4 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 1.4 | 4.3 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 1.4 | 17.1 | GO:0005915 | zonula adherens(GO:0005915) |
| 1.4 | 55.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 1.4 | 7.1 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 1.4 | 2.8 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 1.4 | 201.7 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 1.4 | 7.1 | GO:0032449 | CBM complex(GO:0032449) |
| 1.4 | 12.6 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 1.4 | 4.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 1.4 | 37.4 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 1.4 | 5.5 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 1.4 | 22.0 | GO:0031932 | TORC2 complex(GO:0031932) |
| 1.4 | 6.9 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
| 1.3 | 59.3 | GO:0045095 | keratin filament(GO:0045095) |
| 1.3 | 4.0 | GO:1990393 | 3M complex(GO:1990393) |
| 1.3 | 2.6 | GO:0042025 | host cell nucleus(GO:0042025) host cell nuclear part(GO:0044094) |
| 1.3 | 5.2 | GO:0005960 | glycine cleavage complex(GO:0005960) |
| 1.3 | 9.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
| 1.2 | 55.8 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 1.2 | 46.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 1.2 | 3.6 | GO:0005745 | m-AAA complex(GO:0005745) |
| 1.2 | 30.0 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
| 1.2 | 13.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 1.2 | 94.6 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 1.2 | 7.2 | GO:0060171 | stereocilium membrane(GO:0060171) |
| 1.2 | 5.9 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 1.2 | 3.5 | GO:0035517 | PR-DUB complex(GO:0035517) |
| 1.2 | 11.7 | GO:0008278 | cohesin complex(GO:0008278) |
| 1.1 | 4.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 1.1 | 9.1 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
| 1.1 | 23.8 | GO:0030056 | hemidesmosome(GO:0030056) |
| 1.1 | 10.0 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 1.1 | 3.3 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 1.1 | 14.4 | GO:0036452 | ESCRT complex(GO:0036452) |
| 1.1 | 2.2 | GO:0038201 | TOR complex(GO:0038201) |
| 1.1 | 13.0 | GO:0030008 | TRAPP complex(GO:0030008) |
| 1.1 | 15.0 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 1.1 | 3.2 | GO:0032426 | stereocilium tip(GO:0032426) |
| 1.0 | 4.1 | GO:0070876 | SOSS complex(GO:0070876) |
| 1.0 | 34.8 | GO:0035577 | azurophil granule membrane(GO:0035577) |
| 1.0 | 24.5 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 1.0 | 75.1 | GO:0005643 | nuclear pore(GO:0005643) |
| 1.0 | 13.1 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 1.0 | 7.0 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 1.0 | 12.0 | GO:0030686 | 90S preribosome(GO:0030686) |
| 1.0 | 27.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 1.0 | 34.5 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 1.0 | 2.0 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
| 0.9 | 1.9 | GO:0034518 | RNA cap binding complex(GO:0034518) |
| 0.9 | 20.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.9 | 5.5 | GO:0070554 | synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex(GO:0070554) |
| 0.9 | 4.6 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.9 | 2.7 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
| 0.9 | 7.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
| 0.9 | 9.7 | GO:0005638 | lamin filament(GO:0005638) |
| 0.9 | 54.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.9 | 3.5 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.9 | 52.1 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.9 | 6.0 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.8 | 32.2 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.8 | 2.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
| 0.8 | 3.4 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 0.8 | 4.2 | GO:0000346 | transcription export complex(GO:0000346) |
| 0.8 | 3.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.8 | 9.1 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.8 | 3.3 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
| 0.8 | 0.8 | GO:0001652 | granular component(GO:0001652) |
| 0.8 | 3.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.8 | 4.1 | GO:0071203 | WASH complex(GO:0071203) |
| 0.8 | 11.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.8 | 4.0 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
| 0.8 | 4.7 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
| 0.8 | 365.7 | GO:0005925 | focal adhesion(GO:0005925) |
| 0.8 | 3.1 | GO:0071749 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
| 0.8 | 4.6 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
| 0.8 | 1.5 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
| 0.7 | 1.5 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.7 | 0.7 | GO:0097342 | ripoptosome(GO:0097342) |
| 0.7 | 7.2 | GO:0032039 | integrator complex(GO:0032039) |
| 0.7 | 3.5 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 0.7 | 4.2 | GO:0001673 | male germ cell nucleus(GO:0001673) germ cell nucleus(GO:0043073) |
| 0.7 | 9.7 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.7 | 97.0 | GO:0000793 | condensed chromosome(GO:0000793) |
| 0.7 | 30.8 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.7 | 2.0 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.7 | 14.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
| 0.7 | 4.6 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
| 0.6 | 3.9 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.6 | 3.2 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.6 | 9.9 | GO:0000776 | kinetochore(GO:0000776) |
| 0.6 | 25.5 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
| 0.6 | 3.0 | GO:0032044 | DSIF complex(GO:0032044) |
| 0.6 | 2.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.6 | 18.1 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
| 0.6 | 17.2 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.6 | 5.7 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.6 | 0.6 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.6 | 3.4 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.6 | 8.3 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
| 0.5 | 1.1 | GO:0000805 | X chromosome(GO:0000805) |
| 0.5 | 4.3 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
| 0.5 | 13.0 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.5 | 51.8 | GO:0005903 | brush border(GO:0005903) |
| 0.5 | 3.2 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.5 | 4.8 | GO:0000812 | Swr1 complex(GO:0000812) |
| 0.5 | 2.1 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
| 0.5 | 177.2 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.5 | 4.6 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.5 | 5.6 | GO:0097470 | ribbon synapse(GO:0097470) |
| 0.5 | 2.5 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.5 | 1.9 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
| 0.5 | 5.3 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.5 | 1.4 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.5 | 5.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
| 0.5 | 1.9 | GO:0033263 | CORVET complex(GO:0033263) |
| 0.5 | 0.9 | GO:0070939 | Dsl1p complex(GO:0070939) |
| 0.5 | 32.9 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
| 0.4 | 4.5 | GO:0030904 | retromer complex(GO:0030904) |
| 0.4 | 1.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.4 | 3.9 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| 0.4 | 0.8 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.4 | 7.6 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.4 | 0.8 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
| 0.4 | 0.4 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
| 0.4 | 8.6 | GO:0005861 | troponin complex(GO:0005861) |
| 0.4 | 18.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.4 | 2.0 | GO:0001739 | sex chromatin(GO:0001739) |
| 0.4 | 130.5 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.4 | 1.2 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
| 0.4 | 2.3 | GO:0046930 | pore complex(GO:0046930) |
| 0.4 | 9.5 | GO:0042627 | chylomicron(GO:0042627) |
| 0.4 | 26.8 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.4 | 1.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.4 | 2.8 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.4 | 0.4 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.4 | 2.8 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.3 | 3.5 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.3 | 3.0 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.3 | 3.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.3 | 3.0 | GO:0002102 | podosome(GO:0002102) |
| 0.3 | 3.0 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
| 0.3 | 1.0 | GO:0035363 | histone locus body(GO:0035363) |
| 0.3 | 25.4 | GO:0035579 | specific granule membrane(GO:0035579) |
| 0.3 | 3.5 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.3 | 5.6 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.3 | 1.8 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.3 | 1.8 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.3 | 3.6 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.3 | 16.8 | GO:0005901 | caveola(GO:0005901) |
| 0.3 | 670.3 | GO:0070062 | extracellular exosome(GO:0070062) |
| 0.3 | 1.4 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.3 | 24.3 | GO:0016605 | PML body(GO:0016605) |
| 0.3 | 14.3 | GO:0005811 | lipid particle(GO:0005811) |
| 0.3 | 5.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
| 0.2 | 0.5 | GO:0097449 | astrocyte projection(GO:0097449) |
| 0.2 | 1.2 | GO:1902560 | GMP reductase complex(GO:1902560) |
| 0.2 | 9.9 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
| 0.2 | 0.9 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
| 0.2 | 1.4 | GO:0005879 | axonemal microtubule(GO:0005879) |
| 0.2 | 0.8 | GO:0043196 | varicosity(GO:0043196) |
| 0.2 | 1.0 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.2 | 4.3 | GO:0005844 | polysome(GO:0005844) |
| 0.2 | 0.2 | GO:0071920 | cleavage body(GO:0071920) |
| 0.2 | 1.6 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.2 | 2.8 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.1 | 0.6 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.1 | 13.1 | GO:0031968 | organelle outer membrane(GO:0031968) |
| 0.1 | 3.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 1.2 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.1 | 0.3 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
| 0.1 | 0.4 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.1 | 3.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.1 | 1.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.1 | 0.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.1 | 0.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
| 0.1 | 1.3 | GO:0035580 | specific granule lumen(GO:0035580) |
| 0.1 | 1.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.1 | 0.2 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
| 0.0 | 1.9 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 0.0 | 0.4 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.0 | 0.6 | GO:0032982 | myosin filament(GO:0032982) |
| 0.0 | 6.9 | GO:0005819 | spindle(GO:0005819) |
| 0.0 | 0.9 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
| 0.0 | 0.3 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.0 | 0.1 | GO:0044307 | dendritic branch(GO:0044307) |
| 0.0 | 0.1 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 15.8 | 63.4 | GO:0033897 | ribonuclease T2 activity(GO:0033897) |
| 12.7 | 50.8 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 11.6 | 46.5 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
| 11.2 | 33.5 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
| 10.8 | 43.2 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 10.7 | 42.6 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
| 9.5 | 37.9 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
| 9.4 | 28.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 9.3 | 46.7 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
| 8.7 | 34.8 | GO:0045127 | N-acetylglucosamine kinase activity(GO:0045127) |
| 8.7 | 26.1 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 8.6 | 25.9 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
| 8.3 | 58.2 | GO:0032217 | riboflavin transporter activity(GO:0032217) |
| 7.9 | 23.6 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
| 7.5 | 7.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
| 7.5 | 30.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 7.4 | 22.3 | GO:0009041 | uridylate kinase activity(GO:0009041) |
| 7.4 | 44.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 7.2 | 21.7 | GO:0035731 | S-nitrosoglutathione binding(GO:0035730) dinitrosyl-iron complex binding(GO:0035731) |
| 7.0 | 21.1 | GO:0098808 | mRNA cap binding(GO:0098808) |
| 6.7 | 20.2 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
| 6.7 | 20.0 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 6.6 | 19.8 | GO:0047315 | kynurenine-glyoxylate transaminase activity(GO:0047315) |
| 6.6 | 19.7 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 6.5 | 26.1 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 6.5 | 19.5 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 6.5 | 19.4 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
| 6.4 | 19.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 6.1 | 36.5 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 6.0 | 18.0 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 5.9 | 29.3 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
| 5.8 | 17.3 | GO:0004056 | argininosuccinate lyase activity(GO:0004056) |
| 5.7 | 22.8 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 5.7 | 28.4 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
| 5.7 | 28.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
| 5.6 | 33.7 | GO:0046979 | TAP2 binding(GO:0046979) |
| 5.5 | 16.6 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 5.5 | 44.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 5.5 | 33.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 5.5 | 38.4 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 5.4 | 49.0 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 5.3 | 31.9 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 5.1 | 132.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 5.0 | 30.3 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 5.0 | 15.0 | GO:0004638 | phosphoribosylaminoimidazole carboxylase activity(GO:0004638) phosphoribosylaminoimidazolesuccinocarboxamide synthase activity(GO:0004639) |
| 5.0 | 15.0 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
| 5.0 | 15.0 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
| 4.9 | 14.8 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
| 4.9 | 29.7 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 4.9 | 14.8 | GO:0080023 | 3R-hydroxyacyl-CoA dehydratase activity(GO:0080023) |
| 4.8 | 24.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 4.8 | 14.5 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 4.7 | 14.2 | GO:0055100 | adiponectin binding(GO:0055100) |
| 4.7 | 19.0 | GO:0004360 | glutamine-fructose-6-phosphate transaminase (isomerizing) activity(GO:0004360) |
| 4.7 | 4.7 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
| 4.6 | 32.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 4.6 | 13.8 | GO:0005046 | KDEL sequence binding(GO:0005046) |
| 4.5 | 27.0 | GO:0030620 | U2 snRNA binding(GO:0030620) |
| 4.5 | 22.4 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
| 4.4 | 4.4 | GO:0051717 | inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity(GO:0051717) |
| 4.4 | 35.2 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 4.4 | 122.5 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 4.3 | 17.3 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
| 4.3 | 12.9 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
| 4.2 | 42.2 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 4.2 | 80.0 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 4.2 | 62.3 | GO:0016004 | phospholipase activator activity(GO:0016004) |
| 4.1 | 12.4 | GO:0031755 | endothelial differentiation G-protein coupled receptor binding(GO:0031753) Edg-2 lysophosphatidic acid receptor binding(GO:0031755) |
| 4.1 | 36.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
| 4.1 | 12.2 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 4.0 | 72.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 4.0 | 180.4 | GO:0061650 | ubiquitin conjugating enzyme activity(GO:0061631) ubiquitin-like protein conjugating enzyme activity(GO:0061650) |
| 4.0 | 20.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 3.9 | 15.8 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
| 3.9 | 31.5 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 3.9 | 31.2 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 3.8 | 15.2 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 3.8 | 15.1 | GO:0033823 | procollagen-lysine 5-dioxygenase activity(GO:0008475) procollagen glucosyltransferase activity(GO:0033823) |
| 3.8 | 45.1 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 3.8 | 11.3 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 3.7 | 26.2 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 3.7 | 52.4 | GO:0031386 | protein tag(GO:0031386) |
| 3.7 | 22.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 3.7 | 14.6 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
| 3.6 | 21.9 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 3.6 | 28.9 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
| 3.6 | 7.2 | GO:0031403 | lithium ion binding(GO:0031403) |
| 3.6 | 18.0 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 3.6 | 14.3 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
| 3.6 | 10.7 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 3.5 | 21.2 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 3.5 | 35.1 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 3.5 | 10.5 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
| 3.5 | 14.0 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 3.5 | 17.5 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
| 3.4 | 17.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
| 3.4 | 10.2 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
| 3.4 | 37.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 3.4 | 3.4 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 3.4 | 23.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 3.3 | 16.7 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 3.3 | 13.2 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
| 3.3 | 6.6 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
| 3.3 | 9.8 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) 8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity(GO:0035539) GTP diphosphatase activity(GO:0036219) 2-hydroxy-adenosine triphosphate pyrophosphatase activity(GO:0044713) 2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity(GO:0044714) ATP diphosphatase activity(GO:0047693) |
| 3.2 | 12.9 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 3.2 | 3.2 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
| 3.2 | 9.7 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 3.2 | 12.8 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
| 3.1 | 9.3 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
| 3.1 | 9.3 | GO:0005347 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) ATP transmembrane transporter activity(GO:0005347) purine nucleotide transmembrane transporter activity(GO:0015216) ADP transmembrane transporter activity(GO:0015217) |
| 3.1 | 9.2 | GO:0042947 | glucoside transmembrane transporter activity(GO:0042947) |
| 3.0 | 24.3 | GO:0015288 | porin activity(GO:0015288) |
| 3.0 | 33.3 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 3.0 | 3.0 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
| 3.0 | 56.9 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 3.0 | 26.6 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
| 2.9 | 20.6 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 2.9 | 11.7 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 2.9 | 20.2 | GO:0005497 | androgen binding(GO:0005497) |
| 2.9 | 63.4 | GO:0008494 | translation activator activity(GO:0008494) |
| 2.9 | 2.9 | GO:0032810 | sterol response element binding(GO:0032810) |
| 2.8 | 14.2 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 2.8 | 11.4 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 2.8 | 11.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
| 2.8 | 11.3 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 2.8 | 14.1 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 2.8 | 8.4 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
| 2.8 | 8.4 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 2.8 | 5.6 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 2.8 | 11.0 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 2.7 | 8.2 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
| 2.7 | 19.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 2.7 | 10.9 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
| 2.7 | 10.8 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 2.7 | 37.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 2.7 | 10.7 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
| 2.7 | 10.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 2.6 | 7.9 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 2.6 | 15.6 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 2.6 | 7.8 | GO:0043035 | chromatin insulator sequence binding(GO:0043035) |
| 2.6 | 2.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 2.6 | 51.3 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 2.6 | 46.1 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 2.6 | 23.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 2.6 | 7.7 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
| 2.5 | 7.6 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 2.5 | 20.2 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 2.5 | 9.8 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 2.4 | 55.7 | GO:0044548 | S100 protein binding(GO:0044548) |
| 2.4 | 19.3 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 2.4 | 7.2 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 2.4 | 14.4 | GO:0036033 | mediator complex binding(GO:0036033) |
| 2.3 | 44.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 2.3 | 112.3 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 2.3 | 7.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 2.3 | 27.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
| 2.3 | 43.5 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
| 2.3 | 11.4 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
| 2.3 | 27.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 2.3 | 20.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 2.3 | 4.5 | GO:0048256 | flap endonuclease activity(GO:0048256) |
| 2.2 | 13.5 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 2.2 | 4.5 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 2.2 | 4.5 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 2.2 | 11.1 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
| 2.2 | 13.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 2.2 | 447.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 2.2 | 21.8 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
| 2.2 | 8.7 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 2.2 | 56.1 | GO:0046961 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 2.1 | 6.4 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
| 2.1 | 12.9 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
| 2.1 | 15.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 2.1 | 6.4 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 2.1 | 17.1 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 2.1 | 8.5 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 2.1 | 6.4 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 2.1 | 8.5 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 2.1 | 6.3 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
| 2.1 | 37.8 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 2.1 | 12.6 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 2.1 | 8.2 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 2.1 | 10.3 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 2.1 | 4.1 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
| 2.0 | 16.3 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
| 2.0 | 20.4 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 2.0 | 65.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 2.0 | 16.1 | GO:0050733 | RS domain binding(GO:0050733) |
| 2.0 | 20.1 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 2.0 | 38.2 | GO:0005537 | mannose binding(GO:0005537) |
| 2.0 | 140.2 | GO:0031491 | nucleosome binding(GO:0031491) |
| 2.0 | 12.0 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 2.0 | 6.0 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
| 2.0 | 8.0 | GO:0098770 | FBXO family protein binding(GO:0098770) |
| 2.0 | 13.9 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 2.0 | 59.5 | GO:0008143 | poly(A) binding(GO:0008143) |
| 2.0 | 6.0 | GO:0000252 | C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity(GO:0000252) sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity(GO:0047012) |
| 2.0 | 39.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 2.0 | 7.8 | GO:0035500 | MH2 domain binding(GO:0035500) |
| 1.9 | 23.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 1.9 | 13.4 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
| 1.9 | 3.8 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 1.9 | 61.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
| 1.9 | 11.4 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
| 1.9 | 11.3 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 1.9 | 7.5 | GO:0004335 | galactokinase activity(GO:0004335) |
| 1.9 | 55.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 1.9 | 1.9 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
| 1.9 | 13.0 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 1.9 | 24.1 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
| 1.8 | 7.3 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 1.8 | 12.7 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 1.8 | 3.6 | GO:0070404 | NADH binding(GO:0070404) |
| 1.8 | 27.1 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 1.8 | 86.6 | GO:0050699 | WW domain binding(GO:0050699) |
| 1.8 | 21.4 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
| 1.8 | 12.5 | GO:0051400 | BH domain binding(GO:0051400) |
| 1.8 | 3.6 | GO:0031762 | alpha-1A adrenergic receptor binding(GO:0031691) follicle-stimulating hormone receptor binding(GO:0031762) |
| 1.8 | 8.9 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 1.8 | 7.1 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 1.8 | 10.6 | GO:1990763 | arrestin family protein binding(GO:1990763) |
| 1.8 | 56.1 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 1.7 | 50.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 1.7 | 10.3 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
| 1.7 | 3.4 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 1.7 | 5.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
| 1.7 | 18.6 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 1.7 | 6.8 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 1.7 | 5.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 1.7 | 25.3 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
| 1.7 | 5.1 | GO:0016154 | thymidine phosphorylase activity(GO:0009032) pyrimidine-nucleoside phosphorylase activity(GO:0016154) |
| 1.7 | 10.1 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
| 1.7 | 5.0 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
| 1.7 | 48.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 1.7 | 5.0 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
| 1.7 | 18.4 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 1.7 | 66.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 1.7 | 10.0 | GO:0070513 | death domain binding(GO:0070513) |
| 1.7 | 8.3 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) |
| 1.7 | 3.3 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 1.7 | 29.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 1.6 | 9.9 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 1.6 | 11.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 1.6 | 9.8 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
| 1.6 | 11.4 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 1.6 | 6.5 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
| 1.6 | 8.1 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 1.6 | 24.3 | GO:0015926 | glucosidase activity(GO:0015926) |
| 1.6 | 6.5 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 1.6 | 4.8 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 1.6 | 20.9 | GO:0030515 | snoRNA binding(GO:0030515) |
| 1.6 | 54.5 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 1.6 | 103.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 1.6 | 3.2 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
| 1.6 | 12.7 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
| 1.6 | 14.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 1.6 | 6.3 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
| 1.6 | 36.4 | GO:0070628 | proteasome binding(GO:0070628) |
| 1.6 | 12.6 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 1.5 | 12.4 | GO:0042301 | phosphate ion binding(GO:0042301) |
| 1.5 | 26.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 1.5 | 7.7 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 1.5 | 6.2 | GO:0019826 | oxygen sensor activity(GO:0019826) |
| 1.5 | 4.6 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 1.5 | 9.2 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 1.5 | 12.2 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 1.5 | 4.5 | GO:0004418 | hydroxymethylbilane synthase activity(GO:0004418) |
| 1.5 | 6.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 1.5 | 7.4 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
| 1.5 | 1.5 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
| 1.5 | 25.0 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
| 1.5 | 27.6 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 1.5 | 5.8 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 1.4 | 79.6 | GO:0031593 | polyubiquitin binding(GO:0031593) |
| 1.4 | 30.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 1.4 | 36.0 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 1.4 | 10.1 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 1.4 | 7.2 | GO:0000339 | RNA cap binding(GO:0000339) |
| 1.4 | 10.0 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
| 1.4 | 4.3 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 1.4 | 2.9 | GO:0000182 | rDNA binding(GO:0000182) |
| 1.4 | 4.3 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 1.4 | 11.3 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 1.4 | 5.6 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 1.4 | 11.0 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 1.4 | 8.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 1.4 | 11.0 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
| 1.4 | 2.7 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 1.4 | 14.9 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
| 1.3 | 4.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 1.3 | 6.6 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 1.3 | 9.3 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
| 1.3 | 15.9 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 1.3 | 11.9 | GO:0089720 | caspase binding(GO:0089720) |
| 1.3 | 5.2 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 1.3 | 3.9 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 1.3 | 9.1 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
| 1.3 | 1.3 | GO:0016419 | [acyl-carrier-protein] S-malonyltransferase activity(GO:0004314) S-malonyltransferase activity(GO:0016419) malonyltransferase activity(GO:0016420) |
| 1.3 | 3.8 | GO:0046577 | long-chain-alcohol oxidase activity(GO:0046577) |
| 1.3 | 2.5 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 1.3 | 10.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 1.2 | 34.8 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 1.2 | 11.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 1.2 | 18.5 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
| 1.2 | 3.7 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 1.2 | 4.9 | GO:0051748 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) pyrimidine ribonucleotide binding(GO:0032557) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
| 1.2 | 12.3 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 1.2 | 76.5 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
| 1.2 | 3.6 | GO:0001002 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
| 1.2 | 4.9 | GO:0015266 | protein channel activity(GO:0015266) |
| 1.2 | 2.4 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 1.2 | 15.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 1.2 | 41.6 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 1.2 | 3.6 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 1.2 | 23.6 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 1.2 | 3.5 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 1.2 | 5.8 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 1.2 | 97.4 | GO:0009055 | electron carrier activity(GO:0009055) |
| 1.2 | 4.6 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
| 1.1 | 9.2 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 1.1 | 12.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 1.1 | 6.8 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 1.1 | 27.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 1.1 | 15.7 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 1.1 | 9.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 1.1 | 2.2 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 1.1 | 3.3 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 1.1 | 12.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
| 1.1 | 3.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
| 1.1 | 12.1 | GO:0033691 | sialic acid binding(GO:0033691) |
| 1.1 | 16.4 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 1.1 | 34.9 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 1.1 | 4.3 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 1.1 | 2.2 | GO:0032143 | single thymine insertion binding(GO:0032143) |
| 1.1 | 51.7 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 1.1 | 10.8 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 1.1 | 8.6 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
| 1.1 | 5.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
| 1.1 | 243.1 | GO:0051015 | actin filament binding(GO:0051015) |
| 1.0 | 36.7 | GO:0019956 | chemokine binding(GO:0019956) |
| 1.0 | 4.2 | GO:0043515 | kinetochore binding(GO:0043515) |
| 1.0 | 8.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 1.0 | 2.0 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) |
| 1.0 | 32.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
| 1.0 | 3.0 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 1.0 | 2.0 | GO:0070336 | phosphodiesterase I activity(GO:0004528) flap-structured DNA binding(GO:0070336) |
| 1.0 | 5.0 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 1.0 | 3.0 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
| 1.0 | 15.9 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 1.0 | 5.0 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
| 1.0 | 3.0 | GO:0034736 | sterol O-acyltransferase activity(GO:0004772) cholesterol O-acyltransferase activity(GO:0034736) |
| 1.0 | 8.8 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 1.0 | 3.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 1.0 | 6.7 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.9 | 5.7 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.9 | 8.5 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.9 | 24.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.9 | 25.5 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.9 | 30.3 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.9 | 9.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.9 | 2.8 | GO:0070538 | oleic acid binding(GO:0070538) |
| 0.9 | 5.6 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.9 | 32.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.9 | 0.9 | GO:0043398 | HLH domain binding(GO:0043398) |
| 0.9 | 2.8 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 0.9 | 9.3 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.9 | 6.5 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.9 | 2.8 | GO:0080101 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.9 | 6.4 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 0.9 | 1.8 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.9 | 23.5 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 0.9 | 2.7 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.9 | 2.7 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.9 | 1.8 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.9 | 3.5 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
| 0.9 | 8.7 | GO:0034485 | phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) |
| 0.9 | 3.5 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 0.9 | 2.6 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 0.9 | 8.6 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
| 0.9 | 3.4 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
| 0.8 | 1.7 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.8 | 5.1 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 0.8 | 5.8 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.8 | 57.4 | GO:0019003 | GDP binding(GO:0019003) |
| 0.8 | 2.5 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
| 0.8 | 3.3 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
| 0.8 | 3.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.8 | 2.4 | GO:0052839 | inositol 5-diphosphate pentakisphosphate 5-kinase activity(GO:0052836) inositol diphosphate tetrakisphosphate kinase activity(GO:0052839) |
| 0.8 | 8.0 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.8 | 6.3 | GO:0003696 | satellite DNA binding(GO:0003696) |
| 0.8 | 2.4 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.8 | 48.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.8 | 3.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.8 | 2.4 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.8 | 121.2 | GO:0042393 | histone binding(GO:0042393) |
| 0.8 | 3.9 | GO:0042979 | ornithine decarboxylase inhibitor activity(GO:0008073) ornithine decarboxylase regulator activity(GO:0042979) |
| 0.8 | 39.5 | GO:0015485 | cholesterol binding(GO:0015485) |
| 0.8 | 14.6 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.8 | 11.4 | GO:0031369 | translation initiation factor binding(GO:0031369) |
| 0.8 | 6.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.8 | 2.3 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.8 | 4.5 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.7 | 29.8 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
| 0.7 | 5.2 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.7 | 4.4 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.7 | 70.8 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.7 | 9.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.7 | 3.6 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.7 | 10.1 | GO:0070034 | telomerase RNA binding(GO:0070034) |
| 0.7 | 2.2 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
| 0.7 | 3.6 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.7 | 228.6 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.7 | 15.2 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.7 | 11.0 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.7 | 2.0 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
| 0.7 | 4.0 | GO:0015923 | alpha-mannosidase activity(GO:0004559) mannosidase activity(GO:0015923) |
| 0.7 | 7.4 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
| 0.7 | 2.0 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.6 | 1.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.6 | 3.8 | GO:0004645 | phosphorylase activity(GO:0004645) |
| 0.6 | 2.5 | GO:0102344 | 3-hydroxy-behenoyl-CoA dehydratase activity(GO:0102344) 3-hydroxy-lignoceroyl-CoA dehydratase activity(GO:0102345) |
| 0.6 | 2.5 | GO:0019107 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
| 0.6 | 3.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.6 | 52.0 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.6 | 3.7 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 0.6 | 8.1 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.6 | 1.8 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.6 | 7.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
| 0.6 | 1.2 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.6 | 1.2 | GO:0090079 | translation repressor activity, nucleic acid binding(GO:0000900) translation regulator activity, nucleic acid binding(GO:0090079) |
| 0.6 | 1.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
| 0.6 | 43.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.6 | 10.6 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
| 0.6 | 3.5 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
| 0.6 | 5.2 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.6 | 3.5 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.6 | 19.1 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.6 | 1.7 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
| 0.6 | 1.7 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
| 0.6 | 2.8 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.6 | 3.9 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.6 | 24.5 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.6 | 2.2 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.5 | 2.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
| 0.5 | 4.9 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.5 | 3.8 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.5 | 2.2 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.5 | 2.7 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.5 | 3.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
| 0.5 | 5.3 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
| 0.5 | 1.0 | GO:0004470 | malic enzyme activity(GO:0004470) |
| 0.5 | 1.6 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
| 0.5 | 4.7 | GO:0039706 | co-receptor binding(GO:0039706) |
| 0.5 | 1.0 | GO:0005055 | laminin receptor activity(GO:0005055) |
| 0.5 | 6.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
| 0.5 | 8.7 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.5 | 3.1 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.5 | 3.0 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
| 0.5 | 11.2 | GO:0004407 | histone deacetylase activity(GO:0004407) |
| 0.5 | 5.5 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.5 | 1.0 | GO:0008169 | C-methyltransferase activity(GO:0008169) |
| 0.5 | 1.5 | GO:0048185 | activin binding(GO:0048185) |
| 0.5 | 3.9 | GO:0043426 | MRF binding(GO:0043426) |
| 0.5 | 3.9 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.5 | 1.0 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
| 0.5 | 1.9 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.5 | 1.4 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 0.5 | 1.4 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.5 | 1.4 | GO:0033699 | DNA 5'-adenosine monophosphate hydrolase activity(GO:0033699) |
| 0.5 | 2.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.5 | 3.2 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
| 0.5 | 2.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.5 | 8.6 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.5 | 6.4 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.4 | 1.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
| 0.4 | 15.6 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.4 | 1.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.4 | 6.1 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.4 | 7.4 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.4 | 2.2 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
| 0.4 | 2.2 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.4 | 4.3 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.4 | 0.9 | GO:0016722 | oxidoreductase activity, oxidizing metal ions(GO:0016722) |
| 0.4 | 1.7 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
| 0.4 | 3.4 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.4 | 6.0 | GO:0016208 | AMP binding(GO:0016208) |
| 0.4 | 42.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
| 0.4 | 6.3 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.4 | 2.5 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
| 0.4 | 4.2 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.4 | 0.8 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 0.4 | 0.8 | GO:0003678 | DNA helicase activity(GO:0003678) |
| 0.4 | 2.0 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.4 | 5.6 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
| 0.4 | 38.2 | GO:0047485 | protein N-terminus binding(GO:0047485) |
| 0.4 | 5.1 | GO:0070182 | DNA polymerase binding(GO:0070182) |
| 0.4 | 8.6 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.4 | 64.5 | GO:0003823 | antigen binding(GO:0003823) |
| 0.4 | 1.6 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.4 | 2.7 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.4 | 6.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.4 | 3.4 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
| 0.4 | 1.5 | GO:0016524 | latrotoxin receptor activity(GO:0016524) |
| 0.4 | 2.6 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.4 | 3.7 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.4 | 1.1 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
| 0.4 | 1.5 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
| 0.4 | 1.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
| 0.4 | 2.6 | GO:0048495 | Roundabout binding(GO:0048495) |
| 0.4 | 0.7 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
| 0.4 | 0.7 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.4 | 22.3 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.4 | 32.0 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.3 | 2.4 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.3 | 1.0 | GO:0031626 | beta-endorphin binding(GO:0031626) |
| 0.3 | 2.7 | GO:0019863 | IgE binding(GO:0019863) |
| 0.3 | 3.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
| 0.3 | 1.7 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.3 | 14.2 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.3 | 15.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.3 | 1.3 | GO:0097617 | annealing activity(GO:0097617) |
| 0.3 | 3.9 | GO:0048019 | receptor antagonist activity(GO:0048019) |
| 0.3 | 6.7 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.3 | 1.0 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.3 | 1.0 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.3 | 1.3 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
| 0.3 | 1.3 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
| 0.3 | 0.9 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 0.3 | 4.6 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.3 | 1.2 | GO:1990254 | keratin filament binding(GO:1990254) |
| 0.3 | 131.5 | GO:0003712 | transcription cofactor activity(GO:0003712) |
| 0.3 | 3.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
| 0.3 | 2.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
| 0.3 | 4.2 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.3 | 7.6 | GO:0051219 | phosphoprotein binding(GO:0051219) |
| 0.3 | 2.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.3 | 4.8 | GO:0038191 | neuropilin binding(GO:0038191) |
| 0.3 | 1.1 | GO:0042282 | hydroxymethylglutaryl-CoA reductase (NADPH) activity(GO:0004420) hydroxymethylglutaryl-CoA reductase activity(GO:0042282) |
| 0.3 | 4.5 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.3 | 1.3 | GO:0047844 | deoxycytidine deaminase activity(GO:0047844) |
| 0.3 | 0.8 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.3 | 4.1 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.3 | 1.3 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
| 0.3 | 1.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.2 | 1.2 | GO:0003920 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
| 0.2 | 6.0 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.2 | 0.7 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 0.2 | 1.4 | GO:0098821 | BMP receptor activity(GO:0098821) |
| 0.2 | 3.1 | GO:0019864 | IgG binding(GO:0019864) |
| 0.2 | 6.3 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.2 | 2.1 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
| 0.2 | 2.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
| 0.2 | 0.9 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
| 0.2 | 1.4 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.2 | 1.8 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
| 0.2 | 2.2 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.2 | 5.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.2 | 0.6 | GO:0015226 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
| 0.2 | 5.2 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.2 | 1.6 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.2 | 1.2 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
| 0.2 | 2.6 | GO:0043022 | ribosome binding(GO:0043022) |
| 0.2 | 12.0 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.2 | 1.5 | GO:0050694 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.2 | 5.4 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
| 0.2 | 1.5 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.2 | 2.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.2 | 9.7 | GO:0035326 | enhancer binding(GO:0035326) |
| 0.2 | 1.7 | GO:0004340 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
| 0.2 | 4.7 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.2 | 2.2 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
| 0.2 | 7.9 | GO:0070035 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
| 0.2 | 0.5 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
| 0.2 | 2.9 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.2 | 1.9 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
| 0.2 | 0.5 | GO:0019865 | immunoglobulin binding(GO:0019865) |
| 0.2 | 0.5 | GO:0035605 | aspartic-type endopeptidase inhibitor activity(GO:0019828) peptidyl-cysteine S-nitrosylase activity(GO:0035605) |
| 0.2 | 7.2 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.2 | 1.8 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 0.2 | 0.9 | GO:0008518 | reduced folate carrier activity(GO:0008518) methotrexate transporter activity(GO:0015350) |
| 0.2 | 0.5 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.1 | 1.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.1 | 1.4 | GO:0036041 | long-chain fatty acid binding(GO:0036041) |
| 0.1 | 0.8 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
| 0.1 | 1.0 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.1 | 28.3 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.1 | 0.5 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
| 0.1 | 0.4 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.1 | 1.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.1 | 0.4 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
| 0.1 | 0.2 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
| 0.1 | 1.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
| 0.1 | 2.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 2.7 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.1 | 1.5 | GO:0001848 | complement binding(GO:0001848) |
| 0.1 | 5.2 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 3.9 | GO:0016836 | hydro-lyase activity(GO:0016836) |
| 0.1 | 1.2 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.1 | 0.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.1 | 0.3 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
| 0.1 | 0.4 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.1 | 0.7 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.1 | 0.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.1 | 1.3 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.1 | 0.8 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 0.2 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
| 0.1 | 2.3 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
| 0.1 | 0.2 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
| 0.1 | 0.9 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.1 | 0.8 | GO:0008061 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
| 0.1 | 1.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.1 | 0.4 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.1 | 0.9 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 0.1 | 0.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.1 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
| 0.1 | 0.1 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
| 0.1 | 0.1 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
| 0.1 | 0.8 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.1 | 0.7 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.0 | 1.2 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
| 0.0 | 0.6 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.0 | 0.8 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.0 | 6.3 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
| 0.0 | 0.4 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.0 | 0.2 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
| 0.0 | 0.2 | GO:0045545 | syndecan binding(GO:0045545) |
| 0.0 | 0.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
| 0.0 | 0.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.0 | 0.1 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.0 | 0.1 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.0 | 0.1 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
| 0.0 | 0.1 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.4 | 6.8 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
| 3.4 | 88.2 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 3.4 | 77.7 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 3.2 | 6.5 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
| 3.2 | 35.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
| 2.7 | 8.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 2.2 | 310.1 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
| 2.2 | 95.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
| 2.1 | 82.5 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 2.0 | 31.2 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
| 1.8 | 111.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
| 1.8 | 51.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 1.7 | 71.3 | PID ALK1 PATHWAY | ALK1 signaling events |
| 1.6 | 80.3 | PID ATR PATHWAY | ATR signaling pathway |
| 1.6 | 52.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
| 1.6 | 131.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 1.5 | 3.0 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 1.5 | 32.4 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 1.4 | 66.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 1.3 | 45.7 | PID ATM PATHWAY | ATM pathway |
| 1.3 | 28.0 | PID BARD1 PATHWAY | BARD1 signaling events |
| 1.3 | 25.7 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 1.3 | 99.7 | PID E2F PATHWAY | E2F transcription factor network |
| 1.3 | 70.6 | PID FOXO PATHWAY | FoxO family signaling |
| 1.3 | 87.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 1.2 | 5.0 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 1.2 | 2.3 | PID IL27 PATHWAY | IL27-mediated signaling events |
| 1.2 | 13.9 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
| 1.1 | 45.7 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
| 1.1 | 56.4 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
| 1.1 | 12.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
| 1.0 | 40.1 | PID PLK1 PATHWAY | PLK1 signaling events |
| 1.0 | 13.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 1.0 | 21.3 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.9 | 35.7 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
| 0.9 | 38.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
| 0.9 | 47.7 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
| 0.9 | 47.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.8 | 32.8 | PID AURORA B PATHWAY | Aurora B signaling |
| 0.8 | 8.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.7 | 5.1 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
| 0.7 | 6.3 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.7 | 47.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.7 | 24.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.6 | 57.0 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
| 0.6 | 62.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
| 0.6 | 21.9 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
| 0.6 | 1.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.6 | 12.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.6 | 8.4 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
| 0.5 | 14.5 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
| 0.5 | 18.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.5 | 7.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
| 0.5 | 72.0 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
| 0.5 | 5.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
| 0.5 | 6.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
| 0.4 | 29.6 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.4 | 6.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.4 | 9.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.4 | 3.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
| 0.4 | 68.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.4 | 3.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
| 0.4 | 19.6 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.4 | 12.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.4 | 8.6 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.4 | 11.0 | PID BMP PATHWAY | BMP receptor signaling |
| 0.3 | 17.3 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
| 0.3 | 5.4 | PID ARF 3PATHWAY | Arf1 pathway |
| 0.3 | 4.3 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
| 0.3 | 2.2 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.3 | 8.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.3 | 10.6 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
| 0.3 | 1.6 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.3 | 11.0 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.2 | 10.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.2 | 6.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.2 | 1.8 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
| 0.2 | 4.7 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.1 | 5.4 | PID NOTCH PATHWAY | Notch signaling pathway |
| 0.1 | 6.4 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.1 | 29.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 0.8 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
| 0.1 | 1.0 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
| 0.1 | 2.6 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 1.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
| 0.1 | 1.5 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 0.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.0 | 0.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.0 | 0.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
| 0.0 | 0.6 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.0 | 0.8 | PID P73PATHWAY | p73 transcription factor network |
| 0.0 | 0.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 5.2 | 57.1 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
| 5.1 | 55.8 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
| 4.9 | 44.1 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
| 4.8 | 72.0 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 4.5 | 326.7 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 4.4 | 144.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 4.3 | 64.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
| 4.1 | 61.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 4.1 | 36.5 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
| 3.6 | 81.7 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 3.3 | 69.6 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 3.3 | 3.3 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 3.2 | 6.4 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
| 3.1 | 131.1 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 3.1 | 99.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 3.1 | 33.9 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 3.0 | 30.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
| 3.0 | 50.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 2.9 | 55.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 2.9 | 81.0 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 2.8 | 104.1 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 2.8 | 107.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 2.8 | 41.3 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
| 2.8 | 63.3 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
| 2.7 | 21.9 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 2.7 | 59.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 2.7 | 39.9 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 2.6 | 193.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 2.6 | 72.0 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
| 2.5 | 35.6 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
| 2.4 | 201.1 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 2.4 | 37.7 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 2.3 | 2.3 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
| 2.2 | 258.3 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
| 2.2 | 6.5 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
| 2.2 | 101.2 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 2.1 | 62.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 2.0 | 60.6 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
| 2.0 | 34.3 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
| 1.9 | 15.2 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 1.9 | 7.5 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 1.9 | 54.3 | REACTOME TRANSLATION | Genes involved in Translation |
| 1.9 | 244.5 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
| 1.8 | 1.8 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
| 1.8 | 28.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 1.8 | 40.6 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
| 1.8 | 56.0 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 1.7 | 17.3 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 1.7 | 3.4 | REACTOME E2F MEDIATED REGULATION OF DNA REPLICATION | Genes involved in E2F mediated regulation of DNA replication |
| 1.7 | 64.5 | REACTOME FATTY ACYL COA BIOSYNTHESIS | Genes involved in Fatty Acyl-CoA Biosynthesis |
| 1.7 | 43.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 1.7 | 92.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
| 1.7 | 50.4 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 1.7 | 24.9 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 1.7 | 90.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 1.6 | 51.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
| 1.6 | 25.6 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
| 1.6 | 19.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
| 1.6 | 45.6 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
| 1.6 | 7.8 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
| 1.5 | 93.4 | REACTOME G1 PHASE | Genes involved in G1 Phase |
| 1.5 | 16.5 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 1.5 | 17.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 1.5 | 51.4 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 1.5 | 71.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
| 1.5 | 45.0 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 1.4 | 13.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 1.4 | 31.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
| 1.4 | 11.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
| 1.4 | 11.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
| 1.4 | 43.6 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
| 1.4 | 18.3 | REACTOME SIGNALING BY NOTCH2 | Genes involved in Signaling by NOTCH2 |
| 1.4 | 12.6 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 1.4 | 1.4 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
| 1.4 | 28.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 1.3 | 8.1 | REACTOME M G1 TRANSITION | Genes involved in M/G1 Transition |
| 1.3 | 16.0 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
| 1.3 | 7.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 1.3 | 1.3 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 1.3 | 32.3 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
| 1.3 | 7.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 1.3 | 2.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
| 1.2 | 10.0 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 1.2 | 17.2 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
| 1.2 | 40.4 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 1.2 | 25.3 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 1.2 | 47.8 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 1.2 | 169.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 1.1 | 24.0 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 1.1 | 7.9 | REACTOME G1 S TRANSITION | Genes involved in G1/S Transition |
| 1.1 | 23.7 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
| 1.1 | 3.3 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
| 1.1 | 19.6 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 1.1 | 8.7 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 1.1 | 19.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 1.1 | 4.3 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
| 1.1 | 47.8 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
| 1.0 | 116.8 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
| 1.0 | 14.4 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
| 1.0 | 37.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
| 1.0 | 59.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 1.0 | 63.4 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
| 1.0 | 63.6 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 1.0 | 25.1 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
| 1.0 | 11.0 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
| 0.9 | 9.2 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
| 0.9 | 2.7 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
| 0.9 | 16.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.9 | 16.2 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.9 | 21.8 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.9 | 1.7 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
| 0.9 | 1.7 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
| 0.9 | 7.7 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
| 0.8 | 27.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.8 | 17.0 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
| 0.8 | 3.2 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.8 | 19.0 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.8 | 13.4 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
| 0.8 | 18.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.7 | 7.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.7 | 11.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
| 0.7 | 12.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.7 | 10.2 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
| 0.7 | 32.0 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
| 0.7 | 2.8 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
| 0.7 | 31.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.7 | 6.9 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.7 | 33.3 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
| 0.7 | 6.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
| 0.6 | 8.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.6 | 7.6 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
| 0.6 | 24.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.6 | 11.9 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.6 | 23.8 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
| 0.6 | 5.5 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.5 | 37.4 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
| 0.5 | 15.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
| 0.5 | 5.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.5 | 1.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
| 0.5 | 21.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.5 | 27.2 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
| 0.5 | 9.8 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.5 | 4.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
| 0.4 | 4.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
| 0.4 | 1.6 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.4 | 24.3 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
| 0.4 | 3.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
| 0.4 | 4.1 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
| 0.3 | 38.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
| 0.3 | 8.9 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.3 | 6.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
| 0.3 | 19.9 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.3 | 4.1 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.3 | 3.6 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
| 0.3 | 4.2 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
| 0.3 | 2.1 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
| 0.2 | 7.7 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.2 | 4.0 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
| 0.2 | 11.7 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
| 0.2 | 3.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.2 | 4.4 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
| 0.2 | 11.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.2 | 6.4 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
| 0.2 | 3.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.2 | 4.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.2 | 1.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.2 | 2.7 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
| 0.2 | 0.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
| 0.1 | 12.3 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
| 0.1 | 1.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.1 | 2.9 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
| 0.1 | 2.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 1.8 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.1 | 1.8 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
| 0.1 | 0.7 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
| 0.1 | 3.6 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.1 | 2.0 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
| 0.1 | 3.3 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
| 0.1 | 1.2 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.1 | 13.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
| 0.1 | 1.7 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.1 | 0.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.1 | 1.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.1 | 1.7 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
| 0.1 | 4.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
| 0.1 | 1.3 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.1 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.0 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
| 0.0 | 3.7 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
| 0.0 | 0.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
| 0.0 | 0.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |